<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdcx="http://www.medicuspharma.com/20260930"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdcx-20260930.xsd" xlink:type="simple"/>
    <context id="C_20260101to20260930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20261102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2026-11-02</instant>
        </period>
    </context>
    <context id="C_20260701to20260930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mdcxStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mdcx:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mdcxStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mdcx:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20260101to20260331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20250101to20250331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20250101to20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20260101to20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="C_20260331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20250331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20260401to20260630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20250630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250401to20250630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20260630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:RegulationAOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-10</startDate>
            <endDate>2025-03-10</endDate>
        </period>
    </context>
    <context id="C_20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:RegulationAOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_mdcxMeasurementInputValuationDateSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mdcx:MeasurementInputValuationDateSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:RegulationAOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:RegulationAOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250210to20250210_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-10</startDate>
            <endDate>2025-02-10</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantsIssuedAsPartOfIpoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:WarrantsIssuedAsPartOfIpoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxRegulationAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantWithExpiryDateJune302030WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:WarrantWithExpiryDateJune302030WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantsIssuedAsPartOfIpoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:WarrantsIssuedAsPartOfIpoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_mdcxRegulationAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantWithExpiryDateJune302030WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:WarrantWithExpiryDateJune302030WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxSeriesCAndDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SeriesCAndDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapStatementEquityComponentsAxis_mdcxSeriesCAndDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mdcx:SeriesCAndDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdcx:RegulationAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-10</instant>
        </period>
    </context>
    <context id="C_20250101to20251231_usgaapFinancialInstrumentAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="C_20251231_usgaapFinancialInstrumentAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251229_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-29</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260701to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:SkinjectIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ClinicalManufacturingAndRegulatoryActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:TeverelixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mdcx:ProfessionalServicesAndIntellectualPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250901to20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mdcx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="C_20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mdcx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-17</instant>
        </period>
    </context>
    <context id="C_20260101to20260527_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:DebentureContinuityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-05-27</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:DebentureContinuityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mdcx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20251231_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:DebentureContinuityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260501to20260527_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mdcx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-27</endDate>
        </period>
    </context>
    <context id="C_20260501to20260527_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-27</endDate>
        </period>
    </context>
    <context id="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-27</instant>
        </period>
    </context>
    <context id="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-27</endDate>
        </period>
    </context>
    <context id="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-27</endDate>
        </period>
    </context>
    <context id="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-27</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAAndNoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAAndNoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260527_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:DebentureContinuityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-27</instant>
        </period>
    </context>
    <context id="C_20260528to20260930_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:DebentureContinuityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-28</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-27</instant>
        </period>
    </context>
    <context id="C_20260527_srtRangeAxis_srtMaximumMember_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-27</instant>
        </period>
    </context>
    <context id="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-27</endDate>
        </period>
    </context>
    <context id="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-01</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20260901_srtRangeAxis_srtMaximumMember_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-01</instant>
        </period>
    </context>
    <context id="C_20260901to20260901_srtRangeAxis_srtMaximumMember_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-01</startDate>
            <endDate>2026-09-01</endDate>
        </period>
    </context>
    <context id="C_20260901to20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdcx:NoteA2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mdcx:SecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-01</startDate>
            <endDate>2026-09-01</endDate>
        </period>
    </context>
    <context id="C_20261001to20261103_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mdcx:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-10-01</startDate>
            <endDate>2026-11-03</endDate>
        </period>
    </context>
    <context id="C_20261012to20261012_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-10-12</startDate>
            <endDate>2026-10-12</endDate>
        </period>
    </context>
    <context id="C_20260101to20260131_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-31</endDate>
        </period>
    </context>
    <context id="C_20231018to20231018_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-18</startDate>
            <endDate>2023-10-18</endDate>
        </period>
    </context>
    <context id="C_20260701to20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250701to20250930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:RbxCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260902to20260902_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:PfizerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-02</startDate>
            <endDate>2026-09-02</endDate>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:PfizerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20270902to20270902_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mdcx:Cd228vRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2027-09-02</startDate>
            <endDate>2027-09-02</endDate>
        </period>
    </context>
    <context id="C_20250101to20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="C_20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20260330to20260330_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:DirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-30</startDate>
            <endDate>2026-03-30</endDate>
        </period>
    </context>
    <context id="C_20260601to20260603_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:DirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-06-03</endDate>
        </period>
    </context>
    <context id="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:DirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-27</startDate>
            <endDate>2026-09-27</endDate>
        </period>
    </context>
    <context id="C_20260904to20260904_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:DirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-04</startDate>
            <endDate>2026-09-04</endDate>
        </period>
    </context>
    <context id="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:ConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-09-27</startDate>
            <endDate>2026-09-27</endDate>
        </period>
    </context>
    <context id="C_20260930_mdcxBusinessCombinationConsiderationTransferredEquityInterestTypeAxis_usgaapCommonStockMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mdcx:BusinessCombinationConsiderationTransferredEquityInterestTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_mdcxBusinessCombinationConsiderationTransferredEquityInterestTypeAxis_usgaapCommonStockMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mdcx:BusinessCombinationConsiderationTransferredEquityInterestTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_srtRangeAxis_srtMaximumMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_srtRangeAxis_srtMaximumMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdcx:ContingentConsiderationPhasesFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdcx:AntevLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="C_20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mdcx:PfizerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <unit id="Percent">
        <measure>pure</measure>
    </unit>
    <unit id="Percentage">
        <measure>mdcx:Percentage</measure>
    </unit>
    <unit id="Segment">
        <measure>mdcx:Segment</measure>
    </unit>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_PER_SHARE">
        <measure>mdcx:USD_PER_SHARE</measure>
    </unit>
    <unit id="USD_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Year">
        <measure>mdcx:Year</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="C_20260101to20260930" id="F20250325062249593_0">0001997296</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="C_20260101to20260930" id="F20250325062249593_1">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20260101to20260930" id="F20250325062249593_2">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20260101to20260930"
      id="Fdei_CurrentFiscalYearEndDate20260509003700566">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095332635">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623112859151">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260322150144982">2026-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260322150212142">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095400766">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260810151922184">001-42408</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509004231725">MEDICUS PHARMA LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095428081">A6</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095437970">98-1778211</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095455172">300 Conshohocken State Rd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509004320494">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095509997">W. Conshohocken</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095521671">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095535888">19428</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095546673">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095555746">636-0184</dei:LocalPhoneNumber>
    <dei:Security12gTitle
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220623095613676">Common shares, no par value</dei:Security12gTitle>
    <dei:TradingSymbol
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20230318022908173">MDCX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250325151346309">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12gTitle
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember"
      id="Fxbrl_20260511105600664">Warrants</dei:Security12gTitle>
    <dei:TradingSymbol
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember"
      id="Fxbrl_20260511103901103">MDCXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_usgaapWarrantMember"
      id="Fxbrl_20260511103912746">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623113244591">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095718179">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095732300">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095745301">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095754631">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030165444087">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="C_20260101to20260930"
      id="Fxbrl_20220623095809952">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20261102"
      decimals="INF"
      id="Fxbrl_20260810192557303"
      unitRef="Share">1922837</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185207196"
      unitRef="USD">5019755</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185220671"
      unitRef="USD">8705218</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185211363"
      unitRef="USD">1352609</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185228349"
      unitRef="USD">1086121</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321102225490_xbrl_20250324185211363"
      unitRef="USD">0</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321102225490_xbrl_20250324185228349"
      unitRef="USD">99305</us-gaap:DeferredCostsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185213621"
      unitRef="USD">6372364</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185230475"
      unitRef="USD">9890644</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260812112738426_xbrl_20260321102225490_xbrl_20250324185211363"
      unitRef="USD">8075075</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260812112738426_xbrl_20260321102225490_xbrl_20250324185228349"
      unitRef="USD">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185215866"
      unitRef="USD">89240</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185232983"
      unitRef="USD">170733</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Assets
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185217711"
      unitRef="USD">14536679</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185235659"
      unitRef="USD">10061377</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185546605"
      unitRef="USD">2134134</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185621737"
      unitRef="USD">3435297</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185548578"
      unitRef="USD">1048825</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185623692"
      unitRef="USD">995290</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <mdcx:RelatedPartyPayableCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250325140138511"
      unitRef="USD">162649</mdcx:RelatedPartyPayableCurrent>
    <mdcx:RelatedPartyPayableCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250325140141152"
      unitRef="USD">116476</mdcx:RelatedPartyPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185833660"
      unitRef="USD">107926</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185632506"
      unitRef="USD">145456</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260812113042661_xbrl_20250324185833660"
      unitRef="USD">6000000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260812113042661_xbrl_20250324185632506"
      unitRef="USD">5245543</us-gaap:SecuredDebtCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20261030102707860_xbrl_20260812113042661_xbrl_20250324185833660"
      unitRef="USD">289710</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20261030102707860_xbrl_20260812113042661_xbrl_20250324185632506"
      unitRef="USD">0</us-gaap:InterestPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185556041"
      unitRef="USD">9743244</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185635725"
      unitRef="USD">9938062</us-gaap:LiabilitiesCurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260810095620851_xbrl_20250325140138511"
      unitRef="USD">14986161</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260810095620851_xbrl_20250325140141152"
      unitRef="USD">0</us-gaap:SecuredLongTermDebt>
    <mdcx:InterestPayableNonCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20261030102757938_xbrl_20260810095620851_xbrl_20250325140138511"
      unitRef="USD">283886</mdcx:InterestPayableNonCurrent>
    <mdcx:InterestPayableNonCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20261030102757938_xbrl_20260810095620851_xbrl_20250325140141152"
      unitRef="USD">0</mdcx:InterestPayableNonCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321102232034_xbrl_20250324185211363"
      unitRef="USD">13145</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321102232034_xbrl_20250324185228349"
      unitRef="USD">25865</us-gaap:LongTermLoansPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185558941"
      unitRef="USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185638603"
      unitRef="USD">60139</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185601168"
      unitRef="USD">25026436</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185643822"
      unitRef="USD">10024066</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20260930"
      id="Fxbrl_20260810094937290"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20251231"
      id="Fxbrl_20260810094942483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250325175853688"
      unitRef="USD_Per_Share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324194312776"
      unitRef="USD_Per_Share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324195143853"
      unitRef="Share">1850418</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324195131376"
      unitRef="Share">1850418</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324195110360"
      unitRef="Share">1850418</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250325153820533"
      unitRef="Share">503526</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250325153757310"
      unitRef="Share">503526</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250325153750820"
      unitRef="Share">503526</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockValue
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185603778"
      unitRef="USD">80596102</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185645813"
      unitRef="USD">57076175</us-gaap:CommonStockValue>
    <mdcx:CommonSharesToBeIssued
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321102237428_xbrl_20250324185211363"
      unitRef="USD">0</mdcx:CommonSharesToBeIssued>
    <mdcx:CommonSharesToBeIssued
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321102237428_xbrl_20250324185228349"
      unitRef="USD">313934</mdcx:CommonSharesToBeIssued>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185606115"
      unitRef="USD">9016481</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185648279"
      unitRef="USD">6879575</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321102239953_xbrl_20250324185211363"
      unitRef="USD">40144</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321102239953_xbrl_20250324185228349"
      unitRef="USD">10880</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185608476"
      unitRef="USD">-100189301</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185657379"
      unitRef="USD">-64348118</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321102243202_xbrl_20250324185211363"
      unitRef="USD">-10536574</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321102243202_xbrl_20250324185228349"
      unitRef="USD">-67554</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321102246836_xbrl_20250324185211363"
      unitRef="USD">46817</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321102246836_xbrl_20250324185228349"
      unitRef="USD">104865</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185610766"
      unitRef="USD">-10489757</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185659593"
      unitRef="USD">37311</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324185613231"
      unitRef="USD">14536679</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250324185702202"
      unitRef="USD">10061377</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120307_1"
      unitRef="USD">2507476</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120306_0"
      unitRef="USD">5024082</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120316_31"
      unitRef="USD">14971257</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120316_32"
      unitRef="USD">12720666</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120308_3"
      unitRef="USD">1952780</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120307_2"
      unitRef="USD">1684783</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120317_33"
      unitRef="USD">9564865</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120317_34"
      unitRef="USD">5130561</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030104928764_20261030172120307_1"
      unitRef="USD">10000000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030104928764_20261030172120306_0"
      unitRef="USD">8717475</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030104928764_20261030172120316_31"
      unitRef="USD">10000000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030104928764_20261030172120316_32"
      unitRef="USD">8717475</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120308_5"
      unitRef="USD">14460256</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120308_4"
      unitRef="USD">15426340</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120317_35"
      unitRef="USD">34536122</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120318_36"
      unitRef="USD">26568702</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120309_7"
      unitRef="USD">-14460256</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120309_6"
      unitRef="USD">-15426340</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120318_37"
      unitRef="USD">-34536122</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120318_38"
      unitRef="USD">-26568702</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20260509005723514_20261030172120310_9"
      unitRef="USD">-712652</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20260509005723514_20261030172120309_8"
      unitRef="USD">11572</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120319_39"
      unitRef="USD">-1236441</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120319_40"
      unitRef="USD">75442</us-gaap:InterestIncomeExpenseNet>
    <mdcx:GainLossOnSettlements
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20260509005725117_20261030172120310_9"
      unitRef="USD">0</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20260509005725117_20261030172120309_8"
      unitRef="USD">-157721</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120320_41"
      unitRef="USD">-127083</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120320_42"
      unitRef="USD">-157721</mdcx:GainLossOnSettlements>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20260810102250180_xbrl_20260509005725117_20261030172120310_9"
      unitRef="USD">0</mdcx:ChangeInFairValueOfDebentures>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20260810102250180_xbrl_20260509005725117_20261030172120309_8"
      unitRef="USD">-383823</mdcx:ChangeInFairValueOfDebentures>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260810102250180_20261030172120320_41"
      unitRef="USD">0</mdcx:ChangeInFairValueOfDebentures>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260810102250180_20261030172120320_42"
      unitRef="USD">-583823</mdcx:ChangeInFairValueOfDebentures>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030104933741_20261030172120307_1"
      unitRef="USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030104933741_20261030172120306_0"
      unitRef="USD">-25000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030104933741_20261030172120316_31"
      unitRef="USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030104933741_20261030172120316_32"
      unitRef="USD">-25000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120310_9"
      unitRef="USD">-712652</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120309_8"
      unitRef="USD">-554972</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120320_43"
      unitRef="USD">-1363524</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120321_44"
      unitRef="USD">-691102</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120314_23"
      unitRef="USD">-15172908</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120314_22"
      unitRef="USD">-15981312</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120321_45"
      unitRef="USD">-35899646</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120321_46"
      unitRef="USD">-27259804</us-gaap:ProfitLoss>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030104937276_20261030172120307_1"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030104937276_20261030172120306_0"
      unitRef="USD">4954518</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030104937276_20261030172120316_31"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030104937276_20261030172120316_32"
      unitRef="USD">4954518</mdcx:DeemedDividendOnWarrantInducement>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030104939662_20261030172120307_1"
      unitRef="USD">-15172908</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030104939662_20261030172120306_0"
      unitRef="USD">-20935830</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030104939662_20261030172120316_31"
      unitRef="USD">-35899646</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030104939662_20261030172120316_32"
      unitRef="USD">-32214322</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120310_10"
      unitRef="USD">-21249</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120322_47"
      unitRef="USD">10828</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120322_48"
      unitRef="USD">29680</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120323_49"
      unitRef="USD">10828</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120323_50"
      unitRef="USD">-15194157</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120323_51"
      unitRef="USD">-20925002</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120315_25"
      unitRef="USD">-35869967</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120315_24"
      unitRef="USD">-32203494</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120311_12"
      unitRef="USD">-15181335</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120310_11"
      unitRef="USD">-20935753</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120324_52"
      unitRef="USD">-35841183</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120324_53"
      unitRef="USD">-32214245</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120311_14"
      unitRef="USD">8427</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120311_13"
      unitRef="USD">-77</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120325_54"
      unitRef="USD">-58463</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120331_55"
      unitRef="USD">-77</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120312_16"
      unitRef="USD">-15193860</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120312_15"
      unitRef="USD">-20925077</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120332_56"
      unitRef="USD">-35870383</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120332_57"
      unitRef="USD">-32203569</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120313_18"
      unitRef="USD">-297</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120312_17"
      unitRef="USD">75</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120333_58"
      unitRef="USD">416</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120333_59"
      unitRef="USD">75</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260701to20260930"
      decimals="2"
      id="F20261030172120337_84"
      unitRef="USD_Per_Share">-11.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260701to20260930"
      decimals="2"
      id="F20261030172120313_19"
      unitRef="USD_Per_Share">-11.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250701to20250930"
      decimals="2"
      id="F20261030172120338_87"
      unitRef="USD_Per_Share">-56.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250701to20250930"
      decimals="2"
      id="F20261030172120315_26"
      unitRef="USD_Per_Share">-56.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260101to20260930"
      decimals="2"
      id="F20261030172120338_88"
      unitRef="USD_Per_Share">-35.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260101to20260930"
      decimals="2"
      id="F20261030172120333_60"
      unitRef="USD_Per_Share">-35.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250101to20250930"
      decimals="2"
      id="F20261030172120338_89"
      unitRef="USD_Per_Share">-95.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250101to20250930"
      decimals="2"
      id="F20261030172120334_61"
      unitRef="USD_Per_Share">-95.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120337_86"
      unitRef="Share">1304177</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20260701to20260930"
      decimals="0"
      id="F20261030172120314_21"
      unitRef="Share">1304177</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120337_85"
      unitRef="Share">372633</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20250701to20250930"
      decimals="0"
      id="F20261030172120313_20"
      unitRef="Share">372633</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120339_90"
      unitRef="Share">1019773</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20260101to20260930"
      decimals="0"
      id="F20261030172120334_62"
      unitRef="Share">1019773</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120339_91"
      unitRef="Share">336892</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20250101to20250930"
      decimals="0"
      id="F20261030172120335_63"
      unitRef="Share">336892</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260321120838609_xbrl_20250325144928519"
      unitRef="Share">503526</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321120838609_xbrl_20250325144956857"
      unitRef="USD">57076175</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="INF"
      id="Fxbrl_20260321120838609_xbrl_20251106045621903"
      unitRef="Share">4119</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321124601612"
      unitRef="USD">313934</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321120838609_xbrl_20250325145111663"
      unitRef="USD">6879575</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321120838609_xbrl_20250325145117272"
      unitRef="USD">-64348118</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321124608991"
      unitRef="USD">10880</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321124625180"
      unitRef="USD">104865</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321120838609_xbrl_20250325145121928"
      unitRef="USD">37311</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">106735</mdcx:StockIssuedDuringPeriodSharesConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">4229823</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20251106045713574"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20251106045954378"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20251106045957744"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20260101to20260331"
      decimals="0"
      id="Fxbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">4229823</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithAtTheMarketOfferingNetOfIssuanceCosts
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260321124124958_xbrl_20250325144928519"
      unitRef="Share">189648</mdcx:StockIssuedDuringPeriodSharesConnectionWithAtTheMarketOfferingNetOfIssuanceCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20250325144956857"
      unitRef="USD">5808013</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20260321124030010"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20260321124004517"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20260321124008252"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260101to20260331"
      decimals="0"
      id="Fxbrl_20260321124124958_xbrl_20250325145121928"
      unitRef="USD">5808013</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321125311378"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321125314259"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20250325151831513_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">599306</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321125316410"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321125318666"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321125321097"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260331"
      decimals="0"
      id="Fxbrl_20250325151831513_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">599306</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321125420345"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321125425147"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321125428162"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321121442929_xbrl_20251106050849745_xbrl_20251106050116126"
      unitRef="USD">-9042143</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321125431787"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321121442929_xbrl_20251106050849745_xbrl_20251106050100818"
      unitRef="USD">-168</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260331"
      decimals="0"
      id="Fxbrl_20260321121442929_xbrl_20251106050849745_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-9042311</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054755749"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050023393"
      unitRef="USD">-201390</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050032310"
      unitRef="USD">-2859</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260101to20260331"
      decimals="0"
      id="Fxbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-204249</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192029694"
      unitRef="Share">799909</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192035816"
      unitRef="USD">67114012</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050516320"
      unitRef="Share">4119</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050456969"
      unitRef="USD">313934</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192041478"
      unitRef="USD">7478881</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192047365"
      unitRef="USD">-73390261</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050501329"
      unitRef="USD">-190510</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050504953"
      unitRef="USD">101838</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260331"
      decimals="0"
      id="Fxbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192053814"
      unitRef="USD">1427894</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithAtTheMarketOfferingNetOfIssuanceCosts
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144928519"
      unitRef="Share">375332</mdcx:StockIssuedDuringPeriodSharesConnectionWithAtTheMarketOfferingNetOfIssuanceCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144956857"
      unitRef="USD">6492497</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124030010"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124004517"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124008252"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260401to20260630"
      decimals="0"
      id="Fxbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145121928"
      unitRef="USD">6492497</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodSharesNoncashCompensationServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144928519"
      unitRef="Share">24000</mdcx:StockIssuedDuringPeriodSharesNoncashCompensationServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144956857"
      unitRef="USD">378070</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124030010"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124004517"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124008252"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260401to20260630"
      decimals="0"
      id="Fxbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145121928"
      unitRef="USD">378070</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325144928519"
      unitRef="Share">4119</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325144956857"
      unitRef="USD">313934</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321120838609_xbrl_20251106045621903"
      unitRef="Share">-4119</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321124601612"
      unitRef="USD">-313934</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321124608991"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321124625180"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20260401to20260630"
      decimals="0"
      id="Fxbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325145121928"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20260321125311378"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20260321125314259"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20250325151831513_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">1405826</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20260321125316410"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20260321125318666"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20260321125321097"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630"
      decimals="0"
      id="Fxbrl_20260810113723460_xbrl_20250325151831513_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">1405826</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321125420345"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321125425147"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321125428162"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321121442929_xbrl_20251106050849745_xbrl_20251106050116126"
      unitRef="USD">-11617705</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321125431787"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321121442929_xbrl_20251106050849745_xbrl_20251106050100818"
      unitRef="USD">-66722</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260401to20260630"
      decimals="0"
      id="Fxbrl_20260810114127151_xbrl_20260321121442929_xbrl_20251106050849745_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-11684427</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054755749"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050023393"
      unitRef="USD">251605</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050032310"
      unitRef="USD">3572</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260401to20260630"
      decimals="0"
      id="Fxbrl_20260810114039868_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">255177</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192029694"
      unitRef="Share">1203361</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192035816"
      unitRef="USD">74298513</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050516320"
      unitRef="Share">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050456969"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192041478"
      unitRef="USD">8884707</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192047365"
      unitRef="USD">-85007966</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050501329"
      unitRef="USD">61095</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050504953"
      unitRef="USD">38687</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260630"
      decimals="0"
      id="Fxbrl_20260810114640487_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192053814"
      unitRef="USD">-1724964</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithAtTheMarketOfferingNetOfIssuanceCosts
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20250325144928519"
      unitRef="Share">470469</mdcx:StockIssuedDuringPeriodSharesConnectionWithAtTheMarketOfferingNetOfIssuanceCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20250325144956857"
      unitRef="USD">4755004</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20260321124030010"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20260321124004517"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20260321124008252"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030122747287_xbrl_20260321124124958_xbrl_20250325145121928"
      unitRef="USD">4755004</mdcx:StockIssuedDuringPeriodValueConnectionWithAtTheMarketOfferingNetOfIssuanceCost>
    <mdcx:StockIssuedDuringPeriodSharesNoncashCompensationServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144928519"
      unitRef="Share">6000</mdcx:StockIssuedDuringPeriodSharesNoncashCompensationServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144956857"
      unitRef="USD">88320</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124030010"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124004517"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124008252"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030122803613_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145121928"
      unitRef="USD">88320</mdcx:StockIssuedDuringPeriodValueNoncashCompensationForServicesRendered>
    <mdcx:StockIssuedDuringPeriodSharesInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144928519"
      unitRef="Share">170588</mdcx:StockIssuedDuringPeriodSharesInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325144956857"
      unitRef="USD">1454264</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124030010"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124004517"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20260321124008252"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030122821445_xbrl_20260810120415332_xbrl_20260810113640894_xbrl_20260321124124958_xbrl_20250325145121928"
      unitRef="USD">1454264</mdcx:StockIssuedDuringPeriodValueInLieuOfCashBonuses>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20260321125311378"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20260321125314259"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20250325151831513_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">131775</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20260321125316410"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20260321125318666"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20260321125321097"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030122630013_xbrl_20250325151831513_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">131775</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321125420345"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321125425147"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321125428162"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321121442929_xbrl_20251106050849745_xbrl_20251106050116126"
      unitRef="USD">-15181335</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321125431787"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321121442929_xbrl_20251106050849745_xbrl_20251106050100818"
      unitRef="USD">8427</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030122610661_xbrl_20260321121442929_xbrl_20251106050849745_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-15172908</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054755749"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050023393"
      unitRef="USD">-20952</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050032310"
      unitRef="USD">-297</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-21249</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192029694"
      unitRef="Share">1850418</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192035816"
      unitRef="USD">80596102</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050516320"
      unitRef="Share">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050456969"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192041478"
      unitRef="USD">9016481</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192047365"
      unitRef="USD">-100189301</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050501329"
      unitRef="USD">40144</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050504953"
      unitRef="USD">46817</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20261030122519294_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192053814"
      unitRef="USD">-10489757</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250325144928519"
      unitRef="Share">236334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20250325144956857"
      unitRef="USD">30518195</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="INF"
      id="Fxbrl_20251106045621903"
      unitRef="Share">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321124030010"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20250325145111663"
      unitRef="USD">1520412</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20250325145117272"
      unitRef="USD">-28903903</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321124004517"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321124008252"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20250325145121928"
      unitRef="USD">3134704</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mdcx:IssuanceCostsInConnectionWithRegulationA
      contextRef="C_20250101to20250331"
      decimals="0"
      id="Fxbrl_20260321130439346"
      unitRef="USD">483020</mdcx:IssuanceCostsInConnectionWithRegulationA>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260321153117197"
      unitRef="Share">29800</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321153042823"
      unitRef="USD">2076507</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321121049666_xbrl_20251106045701376"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321121049666_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">1612474</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321121049666_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321121049666_xbrl_20251106045934567"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321121049666_xbrl_20251106045941896"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20250101to20250331"
      decimals="0"
      id="Fxbrl_20260321121049666_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">3688981</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">2116</mdcx:StockIssuedDuringPeriodSharesConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">300000</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045713574"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045954378"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045957744"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250101to20250331"
      decimals="0"
      id="Fxbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">300000</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodSharesUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">100</mdcx:StockIssuedDuringPeriodSharesUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">14000</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106045740351"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050011572"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050014802"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250101to20250331"
      decimals="0"
      id="Fxbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">14000</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325144956857"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">112277</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20251106050023393"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20251106050032310"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250331"
      decimals="0"
      id="Fxbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">112277</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325144956857"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20251106045822777"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">-5102408</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20251106050116126"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20251106050100818"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250331"
      decimals="0"
      id="Fxbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-5102408</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192035816"
      unitRef="Share">268351</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050516320"
      unitRef="USD">32908702</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050456969"
      unitRef="Share">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192041478"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192047365"
      unitRef="USD">3245163</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050501329"
      unitRef="USD">-34006311</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050504953"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250331"
      decimals="0"
      id="Fxbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192053814"
      unitRef="USD">2147554</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mdcx:IssuanceCostsInConnectionWithEquityFinancing
      contextRef="C_20250401to20250630"
      decimals="0"
      id="Fxbrl_20260810120551437"
      unitRef="USD">809606</mdcx:IssuanceCostsInConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">45200</mdcx:StockIssuedDuringPeriodSharesConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">3961899</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106045740351"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">2234495</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050011572"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050014802"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing
      contextRef="C_20250401to20250630"
      decimals="0"
      id="Fxbrl_20260810114904191_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">6196394</mdcx:StockIssuedDuringPeriodValueConnectionWithEquityFinancing>
    <mdcx:StockIssuedDuringPeriodSharesUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">5174</mdcx:StockIssuedDuringPeriodSharesUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">963398</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106045740351"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050011572"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050014802"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250401to20250630"
      decimals="0"
      id="Fxbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">963398</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325144956857"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">117448</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20251106050023393"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20251106050032310"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630"
      decimals="0"
      id="Fxbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">117448</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325144956857"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20251106045822777"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">-6176084</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20251106050116126"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20251106050100818"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250401to20250630"
      decimals="0"
      id="Fxbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-6176084</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192035816"
      unitRef="Share">318725</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050516320"
      unitRef="USD">37833999</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050456969"
      unitRef="Share">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192041478"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192047365"
      unitRef="USD">5597106</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050501329"
      unitRef="USD">-40182395</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050504953"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250630"
      decimals="0"
      id="Fxbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192053814"
      unitRef="USD">3248710</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mdcx:StockIssuedDuringPeriodSharesConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">43053</mdcx:StockIssuedDuringPeriodSharesConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">5254726</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045713574"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045954378"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045957744"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030124517405_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">5254726</mdcx:StockIssuedDuringPeriodValueConnectionWithSepaOfferingCosts>
    <mdcx:StockIssuedDuringPeriodSharesUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">26800</mdcx:StockIssuedDuringPeriodSharesUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">3752000</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106045740351"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050011572"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20251106050014802"
      unitRef="USD">0</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030124438181_xbrl_20260810113942846_xbrl_20260321121249955_xbrl_20251106050608804_xbrl_20250503161759897_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">3752000</mdcx:StockIssuedDuringPeriodValueUponExerciseOfStockWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144928519"
      unitRef="Share">2900</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325144956857"
      unitRef="USD">162400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045713574"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045954378"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045957744"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">162400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325144956857"
      unitRef="USD">27943</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321120838609_xbrl_20251106045621903"
      unitRef="Share">2129410</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321124601612"
      unitRef="Share">4119</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325145111663"
      unitRef="USD">313934</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321124608991"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321124625180"
      unitRef="USD">105161</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030125941389_xbrl_20260810114458150_xbrl_20260321120838609_xbrl_20250325145121928"
      unitRef="USD">2548505</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054755749"
      unitRef="USD">653504</mdcx:ShareIssuanceCosts>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106045811216"
      unitRef="USD">0</mdcx:ShareIssuanceCosts>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</mdcx:ShareIssuanceCosts>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:ShareIssuanceCosts>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050023393"
      unitRef="USD">0</mdcx:ShareIssuanceCosts>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050032310"
      unitRef="USD">0</mdcx:ShareIssuanceCosts>
    <mdcx:ShareIssuanceCosts
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030130232134_xbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">653504</mdcx:ShareIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325144956857"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">852757</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20251106050023393"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20251106050032310"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030124447063_xbrl_20260810113917847_xbrl_20260321120741328_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">852757</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030172038965"
      unitRef="USD">0</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030172117190"
      unitRef="USD">0</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">4954518</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045954378"
      unitRef="USD">0</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045957744"
      unitRef="USD">0</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:WarrantsIssuedUnderWarrantInducement
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">4954518</mdcx:WarrantsIssuedUnderWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030172051883"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030172102559"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030130246396_xbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145111663"
      unitRef="USD">4954518</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030130246396_xbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145117272"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030130246396_xbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045954378"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030130246396_xbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20251106045957744"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030130246396_xbrl_20261030130140745_xbrl_20261030124530265_xbrl_20260509011751740_xbrl_20260321121109065_xbrl_20250503161758184_xbrl_20250503134537353_xbrl_20250325145121928"
      unitRef="USD">4954518</mdcx:DeemedDividendOnWarrantInducement>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325144956857"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20251106045822777"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">-15981235</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20251106050116126"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20251106050100818"
      unitRef="USD">-77</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030124500893_xbrl_20260810113848230_xbrl_20260321120759983_xbrl_20250325151300282_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">-15981312</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054755749"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106045811216"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145111663"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145117272"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050023393"
      unitRef="USD">10676</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20251106050032310"
      unitRef="USD">152</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20261030125622420_xbrl_20261030122548414_xbrl_20260321121508234_xbrl_20251106054640966_xbrl_20251106050725954_xbrl_20250325151258473_xbrl_20250325151118378_xbrl_20250325145121928"
      unitRef="USD">10828</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192035816"
      unitRef="Share">419421</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050516320"
      unitRef="USD">48479031</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050456969"
      unitRef="Share">4119</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_mdcxSharesIssuedMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192041478"
      unitRef="USD">313934</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192047365"
      unitRef="USD">6449863</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050501329"
      unitRef="USD">-56163630</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fxbrl_20261030125816447"
      unitRef="USD">10676</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251106050504953"
      unitRef="USD">105236</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20250930"
      decimals="0"
      id="Fxbrl_20261030125557327_xbrl_20260810113755227_xbrl_20260509011805398_xbrl_20260321121514349_xbrl_20251106051038336_xbrl_20251105192053814"
      unitRef="USD">-804890</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111840933_xbrl_20250325115322380"
      unitRef="USD">-35899646</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111840933_xbrl_20250325115328019"
      unitRef="USD">-27259804</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737911_xbrl_20250325130311306"
      unitRef="USD">2136908</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737911_xbrl_20250325130455375"
      unitRef="USD">1082482</us-gaap:ShareBasedCompensation>
    <us-gaap:PaidInKindInterest
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737920_xbrl_20250809010611002_xbrl_20250325130317063"
      unitRef="USD">847893</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737920_xbrl_20250809010611002_xbrl_20250325130501370"
      unitRef="USD">89680</us-gaap:PaidInKindInterest>
    <mdcx:IncreaseDecreaseInOperatingLeaseRightofuseAssets
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737912_xbrl_20250325130317063"
      unitRef="USD">81493</mdcx:IncreaseDecreaseInOperatingLeaseRightofuseAssets>
    <mdcx:IncreaseDecreaseInOperatingLeaseRightofuseAssets
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737912_xbrl_20250325130501370"
      unitRef="USD">72322</mdcx:IncreaseDecreaseInOperatingLeaseRightofuseAssets>
    <mdcx:GainLossOnSettlements
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">-127083</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">-157721</mdcx:GainLossOnSettlements>
    <mdcx:IncreaseDecreaseInChangeInFairValueOfDebentures
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131719359_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">0</mdcx:IncreaseDecreaseInChangeInFairValueOfDebentures>
    <mdcx:IncreaseDecreaseInChangeInFairValueOfDebentures
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131719359_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">583823</mdcx:IncreaseDecreaseInChangeInFairValueOfDebentures>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131720775_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131720775_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">-25000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131722365_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131722365_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">8717475</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <mdcx:IncreaseDecreaseInCostsRelatedToSettlements
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131724314_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">0</mdcx:IncreaseDecreaseInCostsRelatedToSettlements>
    <mdcx:IncreaseDecreaseInCostsRelatedToSettlements
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131724314_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">300000</mdcx:IncreaseDecreaseInCostsRelatedToSettlements>
    <mdcx:CostsToIssueDebenturesAndSecuredPromissoryNotes
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260810105604189_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">0</mdcx:CostsToIssueDebenturesAndSecuredPromissoryNotes>
    <mdcx:CostsToIssueDebenturesAndSecuredPromissoryNotes
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260810105604189_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">111725</mdcx:CostsToIssueDebenturesAndSecuredPromissoryNotes>
    <mdcx:IssuanceOfCommonSharesConnectionWithNonCashCompensationForServicesRendered
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260810105606137_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">466390</mdcx:IssuanceOfCommonSharesConnectionWithNonCashCompensationForServicesRendered>
    <mdcx:IssuanceOfCommonSharesConnectionWithNonCashCompensationForServicesRendered
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260810105606137_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">0</mdcx:IssuanceOfCommonSharesConnectionWithNonCashCompensationForServicesRendered>
    <mdcx:IssuanceOfRestrictedSecuritiesInLieuOfCashBonuses
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131726875_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">1454264</mdcx:IssuanceOfRestrictedSecuritiesInLieuOfCashBonuses>
    <mdcx:IssuanceOfRestrictedSecuritiesInLieuOfCashBonuses
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131726875_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">0</mdcx:IssuanceOfRestrictedSecuritiesInLieuOfCashBonuses>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131729157_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131729157_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">-8816</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737926_xbrl_20250325115752505"
      unitRef="USD">257533</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737926_xbrl_20250325115849101"
      unitRef="USD">-317522</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737929_xbrl_20250325115755346"
      unitRef="USD">-1411105</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737929_xbrl_20250325115851240"
      unitRef="USD">-380033</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737931_xbrl_20250325115757810"
      unitRef="USD">49625</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737931_xbrl_20250325115859128"
      unitRef="USD">111167</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030131734844_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130311306"
      unitRef="USD">573596</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030131734844_xbrl_20260321111737922_xbrl_20251105165758290_xbrl_20250325130455375"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737933_xbrl_20250325115800060"
      unitRef="USD">-109009</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737933_xbrl_20250325115901950"
      unitRef="USD">-106171</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737935_xbrl_20250325115803074"
      unitRef="USD">46173</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737935_xbrl_20250325115857197"
      unitRef="USD">621</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737937_xbrl_20250325115805768"
      unitRef="USD">-31893868</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737937_xbrl_20250325115904539"
      unitRef="USD">-16167654</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">9790015</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030141828151_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030141828151_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">5097005</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260810111159411_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">22000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260810111159411_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">11866293</us-gaap:ProceedsFromIssuanceOfDebt>
    <mdcx:ProceedsFromIssuanceOfCommonStockAtTheMarketOfferingNetOfIssuanceCosts
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260509015831576_xbrl_20260321112129228_xbrl_20251105183204922_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">17154819</mdcx:ProceedsFromIssuanceOfCommonStockAtTheMarketOfferingNetOfIssuanceCosts>
    <mdcx:ProceedsFromIssuanceOfCommonStockAtTheMarketOfferingNetOfIssuanceCosts
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260509015831576_xbrl_20260321112129228_xbrl_20251105183204922_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">0</mdcx:ProceedsFromIssuanceOfCommonStockAtTheMarketOfferingNetOfIssuanceCosts>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260810111201315_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260810111201315_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">4729398</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030141830608_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030141830608_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">162400</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260810111203246_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">615000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260810111203246_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">136726</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030134100353"
      unitRef="USD">6397262</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321112059420_xbrl_20251105165808130_xbrl_20250325130455375"
      unitRef="USD">5637709</us-gaap:RepaymentsOfDebt>
    <mdcx:ProceedsFromIssuanceOfSharesUnderSettlements
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321112129228_xbrl_20251105183204922_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">4102740</mdcx:ProceedsFromIssuanceOfSharesUnderSettlements>
    <mdcx:ProceedsFromIssuanceOfSharesUnderSettlements
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321112129228_xbrl_20251105183204922_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">0</mdcx:ProceedsFromIssuanceOfSharesUnderSettlements>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030141833820_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030141833820_xbrl_20260321113859805_xbrl_20260321112041265_xbrl_20251105165804188_xbrl_20250325130455375"
      unitRef="USD">584361</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737953_xbrl_20250325115820829"
      unitRef="USD">36245297</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737953_xbrl_20250325115921653"
      unitRef="USD">25286315</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030142850500_xbrl_20260321111737961_xbrl_20251105165823133_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030142850500_xbrl_20260321111737961_xbrl_20251105165823133_xbrl_20250325130455375"
      unitRef="USD">4619152</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030142851637_xbrl_20260321111737961_xbrl_20251105165823133_xbrl_20250325130311306"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030142851637_xbrl_20260321111737961_xbrl_20251105165823133_xbrl_20250325130455375"
      unitRef="USD">-4619152</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321111737961_xbrl_20251105165823133_xbrl_20250325130311306"
      unitRef="USD">38183</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321111737961_xbrl_20251105165823133_xbrl_20250325130455375"
      unitRef="USD">-1741</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321112144595_xbrl_20251105165823133_xbrl_20250325130311306"
      unitRef="USD">4389612</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321112144595_xbrl_20251105165823133_xbrl_20250325130455375"
      unitRef="USD">4497768</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321112149025_xbrl_20250325115828192"
      unitRef="USD">8705218</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20260321112149025_xbrl_20250325115927259"
      unitRef="USD">4164323</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321112202767_xbrl_20250325115830759"
      unitRef="USD">13094830</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250930"
      decimals="0"
      id="Fxbrl_20260321112202767_xbrl_20250325115931676"
      unitRef="USD">8662091</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321113925782_xbrl_20260321112224885_xbrl_20251107154602864"
      unitRef="USD">330626</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321113925782_xbrl_20260321112224885_xbrl_20251107154609823"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030143513228_xbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124516894"
      unitRef="USD">0</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:DeemedDividendOnWarrantInducement
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030143513228_xbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124531877"
      unitRef="USD">4954518</mdcx:DeemedDividendOnWarrantInducement>
    <mdcx:SharesIssuedForAcquisitionOfAntev
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030143514880_xbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124516894"
      unitRef="USD">0</mdcx:SharesIssuedForAcquisitionOfAntev>
    <mdcx:SharesIssuedForAcquisitionOfAntev
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030143514880_xbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124531877"
      unitRef="USD">2129410</mdcx:SharesIssuedForAcquisitionOfAntev>
    <mdcx:SharesToBeIssuedForAcquisitionOfAntev
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030143516937_xbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124516894"
      unitRef="USD">0</mdcx:SharesToBeIssuedForAcquisitionOfAntev>
    <mdcx:SharesToBeIssuedForAcquisitionOfAntev
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030143516937_xbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124531877"
      unitRef="USD">313934</mdcx:SharesToBeIssuedForAcquisitionOfAntev>
    <mdcx:DeferredIssuanceCostsOnIssuedSharesRelatedToSepaAgreement
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124516894"
      unitRef="USD">0</mdcx:DeferredIssuanceCostsOnIssuedSharesRelatedToSepaAgreement>
    <mdcx:DeferredIssuanceCostsOnIssuedSharesRelatedToSepaAgreement
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321112336068_xbrl_20251105190829309_xbrl_20250326124531877"
      unitRef="USD">300000</mdcx:DeferredIssuanceCostsOnIssuedSharesRelatedToSepaAgreement>
    <mdcx:IssuanceCostsIncludedInAccountsPayable
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321112303177_xbrl_20250326124516894"
      unitRef="USD">0</mdcx:IssuanceCostsIncludedInAccountsPayable>
    <mdcx:IssuanceCostsIncludedInAccountsPayable
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260321112303177_xbrl_20250326124531877"
      unitRef="USD">95360</mdcx:IssuanceCostsIncludedInAccountsPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323190950558">
    &lt;p style="margin-left:17.85pt;text-indent:-17.85pt;text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1. Description of business&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Medicus Pharma Ltd. (the "Company"), formerly Interactive Capital Partners Corporation, is a clinical stage, multi-strategy, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is a public limited company originally incorporated pursuant to the provisions of the &lt;i&gt;Business Corporations Act&lt;/i&gt; (Ontario) on April 30, 2008, as a private company named Interactive Capital Partners Corporation, with nominal assets and liabilities. The Company's registered office is located at 100 King Street West, Suite 3400, One First Canadian Place, Toronto, Ontario, Canada, and its head office is located at 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323220925857">
    &lt;p style="margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2. Summary of significant accounting policies &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basis of presentation and consolidation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The accompanying unaudited condensed consolidated financial statements included herein have been prepared in conformity with generally accepted accounting principles in the United States ("GAAP") and under the rules and regulations of the United States Securities and Exchange Commission ("SEC") for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company's financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC's rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December 31, 2025, included in the Company's Annual Report on Form 10-K, as amended, originally filed with the SEC on March 25, 2026 (the "2025 Annual Report"). These condensed consolidated financial statements include the financial statements of the Company and its subsidiaries, SkinJect, Inc. (&#x201c;SkinJect&#x201d;), Medicus Pharma Inc., Antev Limited ("Antev") and MDCX Holdings, LLC. All intercompany balances and transactions have been eliminated on consolidation. Non-controlling interest in the consolidated financial statements represents the portion of Antev not 100% owned by the Company. The functional currency of the Company and its three wholly-owned subsidiaries, SkinJect, Inc., Medicus Pharma Inc. and MDCX Holdings, LLC is the United States dollar (USD). The functional currency of the Company's other subsidiary, Antev is Pound Sterling (GBP).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Foreign operations remeasurement and translation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates, are generally recognized in the condensed consolidated statements of operations and comprehensive loss. The results and financial position of foreign operation which has functional currency different from presentation currency are translated into the presentation currency as follows: assets and liabilities are translated at the closing rate at the date of that statement of financial position, income and expenses are translated at average exchange rates, and all resulting translated exchange differences are recognized in a separate component of other comprehensive loss within the condensed consolidated statement of changes in shareholders equity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Use of estimates&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of these condensed consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of income and expenses during the reporting period. Such estimates include the valuation of stock-based awards, the incremental borrowing rate used to discount the Company's operating lease liabilities, fair value of the Company's debentures and secured promissory notes and warrants, and valuation allowance on deferred tax assets, all of which are management's best estimates. Estimates are based on historical experience, where applicable, and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. By their nature, these estimates are subject to measurement uncertainty and the effect on the financial statements of changes in estimates in future years could be significant. Management believes that the estimates utilized in preparing the financial statements are reasonable, however, actual results could differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
    &lt;div&gt;
      &lt;div&gt;&lt;/div&gt;
    &lt;/div&gt;

      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Operating segments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating segments are identified as components of an entity about which separate discrete financial information is available for evaluation by the chief operating decision-maker ("CODM") in making decisions regarding resource allocation and assessing performance. The Company views its operations and manages its business in one operating segment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Recently issued accounting pronouncements &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2024, the FASB issued ASU 2024-03 "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures" to provide greater transparency about the components of specific expense categories in the income statements. The effective dates of ASU 2024-03 were subsequently clarified by ASU 2025-01. ASU 2025-01 is effective for our annual period beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting the amendment on the Company's financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;There were no other significant updates to the recently issued accounting standards which may be applicable to the Company. Although there are several other new accounting pronouncements issued or proposed by the FASB, the Company does not believe any of those accounting pronouncements have had or will have a material impact on its financial position or operating results.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

  </us-gaap:SignificantAccountingPoliciesTextBlock>
    <mdcx:BasisOfPresentationAndConsolidationPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323221121886">
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basis of presentation and consolidation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The accompanying unaudited condensed consolidated financial statements included herein have been prepared in conformity with generally accepted accounting principles in the United States ("GAAP") and under the rules and regulations of the United States Securities and Exchange Commission ("SEC") for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company's financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC's rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December 31, 2025, included in the Company's Annual Report on Form 10-K, as amended, originally filed with the SEC on March 25, 2026 (the "2025 Annual Report"). These condensed consolidated financial statements include the financial statements of the Company and its subsidiaries, SkinJect, Inc. (&#x201c;SkinJect&#x201d;), Medicus Pharma Inc., Antev Limited ("Antev") and MDCX Holdings, LLC. All intercompany balances and transactions have been eliminated on consolidation. Non-controlling interest in the consolidated financial statements represents the portion of Antev not 100% owned by the Company. The functional currency of the Company and its three wholly-owned subsidiaries, SkinJect, Inc., Medicus Pharma Inc. and MDCX Holdings, LLC is the United States dollar (USD). The functional currency of the Company's other subsidiary, Antev is Pound Sterling (GBP).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </mdcx:BasisOfPresentationAndConsolidationPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260321123839001">
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Foreign operations remeasurement and translation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates, are generally recognized in the condensed consolidated statements of operations and comprehensive loss. The results and financial position of foreign operation which has functional currency different from presentation currency are translated into the presentation currency as follows: assets and liabilities are translated at the closing rate at the date of that statement of financial position, income and expenses are translated at average exchange rates, and all resulting translated exchange differences are recognized in a separate component of other comprehensive loss within the condensed consolidated statement of changes in shareholders equity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323221204705">
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Use of estimates&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of these condensed consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of income and expenses during the reporting period. Such estimates include the valuation of stock-based awards, the incremental borrowing rate used to discount the Company's operating lease liabilities, fair value of the Company's debentures and secured promissory notes and warrants, and valuation allowance on deferred tax assets, all of which are management's best estimates. Estimates are based on historical experience, where applicable, and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. By their nature, these estimates are subject to measurement uncertainty and the effect on the financial statements of changes in estimates in future years could be significant. Management believes that the estimates utilized in preparing the financial statements are reasonable, however, actual results could differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323221856028">
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Operating segments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating segments are identified as components of an entity about which separate discrete financial information is available for evaluation by the chief operating decision-maker ("CODM") in making decisions regarding resource allocation and assessing performance. The Company views its operations and manages its business in one operating segment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260509005724318"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323221934096">
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Recently issued accounting pronouncements &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2024, the FASB issued ASU 2024-03 "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures" to provide greater transparency about the components of specific expense categories in the income statements. The effective dates of ASU 2024-03 were subsequently clarified by ASU 2025-01. ASU 2025-01 is effective for our annual period beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting the amendment on the Company's financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;There were no other significant updates to the recently issued accounting standards which may be applicable to the Company. Although there are several other new accounting pronouncements issued or proposed by the FASB, the Company does not believe any of those accounting pronouncements have had or will have a material impact on its financial position or operating results.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260321100201840">
    &lt;div&gt;
      &lt;p style="margin-left:17.85pt;text-indent:-17.85pt;text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.&lt;/strong&gt;&#160;&lt;strong&gt;Balance sheet components&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses and other current assets include the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Insurance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;345,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract research organizations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;390,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;410,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;312,275&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300,033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;VAT receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;625,992&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,342&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,004&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,352,609&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,086,121&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued expenses and other current liabilities include the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued legal fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;264,891&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;352,864&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;216,002&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300,181&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued other&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;567,932&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;342,245&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,048,825&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;995,290&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <mdcx:ScheduleOfPrepaidExpensesTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260321100214534">
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;border-top:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Insurance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;345,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract research organizations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;390,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;410,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;312,275&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300,033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;VAT receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;625,992&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,342&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,004&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,352,609&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,086,121&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </mdcx:ScheduleOfPrepaidExpensesTableTextBlock>
    <us-gaap:PrepaidInsurance
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323225637621"
      unitRef="USD">0</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323225919745"
      unitRef="USD">345084</us-gaap:PrepaidInsurance>
    <mdcx:PrepaidContractResearch
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323225802395"
      unitRef="USD">390000</mdcx:PrepaidContractResearch>
    <mdcx:PrepaidContractResearch
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323225934485"
      unitRef="USD">410000</mdcx:PrepaidContractResearch>
    <mdcx:PrepaidProfessionalServices
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323225820626"
      unitRef="USD">312275</mdcx:PrepaidProfessionalServices>
    <mdcx:PrepaidProfessionalServices
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323225941575"
      unitRef="USD">300033</mdcx:PrepaidProfessionalServices>
    <us-gaap:ValueAddedTaxReceivableCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20261030003306433_xbrl_20250323225820626"
      unitRef="USD">625992</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20261030003306433_xbrl_20250323225941575"
      unitRef="USD">0</us-gaap:ValueAddedTaxReceivableCurrent>
    <mdcx:PrepaidServices
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323225833496"
      unitRef="USD">24342</mdcx:PrepaidServices>
    <mdcx:PrepaidServices
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323230008285"
      unitRef="USD">31004</mdcx:PrepaidServices>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323225900903"
      unitRef="USD">1352609</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260810183443310"
      unitRef="USD">1086121</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323225619934">
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued legal fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;264,891&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;352,864&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;216,002&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300,181&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued other&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;567,932&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;342,245&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,048,825&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;995,290&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323230109336"
      unitRef="USD">264891</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323230126130"
      unitRef="USD">352864</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323230147827"
      unitRef="USD">216002</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323230259340"
      unitRef="USD">300181</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323230240468"
      unitRef="USD">567932</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323230316942"
      unitRef="USD">342245</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323230225428"
      unitRef="USD">1048825</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323230326696"
      unitRef="USD">995290</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509010341744">
    &lt;p style="margin-left:17pt;text-indent:-17pt;text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4. Leases&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of September 30, 2026, the Company had one operating lease for its corporate office that commenced in 2024, for which the Company recorded a right-of-use asset and lease liability as of the commencement date. The Company's lease does not contain a purchase option. Where the Company's lease contains an option to extend the lease term, the extended lease term is only included in the measurement of the lease when it is reasonably certain to remain in the lease beyond the non-cancellable term. The Company's lease also contains variable lease costs, which pertain to common area maintenance and other operating charges, that are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance sheet information related to the Company's lease is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;As of&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;As of&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Operating lease&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;89,240&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;170,733&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107,926&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,456&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;

    &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other information related to leases is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td colspan="4" style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine months ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92,483&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(109,009&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(106,171&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remaining lease term (in years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;

    &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of September 30, 2026, the annual future minimum lease payments of the Company's operating lease liabilities were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:60%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;37,174&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;74,348&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;Total future minimum lease payments, undiscounted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;111,522&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Present value discount&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,596&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0)"&gt;)&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;107,926&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

  </us-gaap:LesseeOperatingLeasesTextBlock>
    <mdcx:LesseeOperatingLeasesDisclosureTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323230512381">
      &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;As of&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;As of&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Operating lease&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;89,240&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;170,733&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107,926&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,456&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
    </mdcx:LesseeOperatingLeasesDisclosureTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321100722615"
      unitRef="USD">89240</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323231135654"
      unitRef="USD">170733</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321100728265"
      unitRef="USD">107926</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323231148017"
      unitRef="USD">145456</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321100734695"
      unitRef="USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20250323231214952"
      unitRef="USD">60139</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250323230540980">
      &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td colspan="4" style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine months ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92,483&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(109,009&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(106,171&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remaining lease term (in years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
    </us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321100521993"
      unitRef="USD">92833</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20250323231231585"
      unitRef="USD">92483</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260321100533032"
      unitRef="USD">109009</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20250323231246011"
      unitRef="USD">106171</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="C_20260930" id="Fxbrl_20260321100538623">P0Y9M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="C_20250930" id="Fxbrl_20250323231302002">P1Y9M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20260321100546455"
      unitRef="Percent">0.10</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="C_20250930"
      decimals="2"
      id="Fxbrl_20250323231338153"
      unitRef="Percent">0.10</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030234648478">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:60%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;37,174&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;74,348&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:#231f20"&gt;Total future minimum lease payments, undiscounted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;111,522&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Present value discount&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,596&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0)"&gt;)&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;107,926&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323231412976"
      unitRef="USD">37174</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323232600160"
      unitRef="USD">74348</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323232614195"
      unitRef="USD">111522</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323232634471"
      unitRef="USD">3596</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250323232646916"
      unitRef="USD">107926</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509013512151">
    &lt;div&gt;
      &lt;p style="margin-left:17pt;text-indent:-17.85pt;text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5. Share capital&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Authorized&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has authorized an unlimited number of common shares participating, voting and without nominal or par value. Each holder of common shares is entitled to one vote for each share owned on all matters voted upon by shareholders.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Share Consolidation&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the Company's 2026 Annual General meeting and Special Meeting held on June 3, 2026, the Company's shareholders approved a proposal authorizing the Company's board of directors to effect a consolidation of the common shares at a ratio of up to 50-to-1. Subsequently, the Company's board of directors approved a share consolidation of the Company's common shares on a 50-to-1 basis, which became effective on October 12, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;
        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;As a result of the share consolidation, every 50 pre-split common shares issued and outstanding were automatically combined into one new common share. No fractional common shares were issued in connection with the consolidation. Shareholders who otherwise were entitled to receive a fractional share because they held a number of shares not evenly divisible by the share consolidation ratio were rounded down to the next whole share with cash paid in lieu of such fractional shares.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the anti-dilution provisions of the Company's option and warrant agreements, the 50-to-1 share consolidation proportionally adjusted the terms of all outstanding options and warrants, so that 50 options or warrants are now required to purchase one common share. Accordingly, the number of options and warrants outstanding remain unchanged under the original agreements. However, the number of common shares that the options and warrants can be exercised for were adjusted to reflect the share consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;All share, option, warrant and per share amounts in the accompanying unaudited condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the share consolidation for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Regulation A Offering&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 10, 2025, the Company closed a Tier II Regulation A offering for gross proceeds of $4,172,000. The Company issued 29,800 units at a price of $140 per unit. Each unit consisted of one common share of the Company and one warrant to purchase one common share of the Company (each a "Regulation A Warrant"). The Regulation A Warrants have an exercise price of $140 per share and will expire 5 years from the date of issuance on March 10, 2030. The Company incurred total issuance costs of $483,020, including legal fees and placement fees directly related to the issuance. The issuance costs incurred were recognized as a reduction in equity and allocated based on the relative fair values of the Regulation A Warrants and common shares on a standalone basis. The fair value of the common shares was based on the Company's share price on the day of issuance of $170 and the fair value of the Regulation A Warrants was $131.50 per warrant. The Regulation A Warrants were recognized in additional paid-in capital as they met the criteria for equity classification.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's Regulation A Warrants are not actively traded and are therefore classified as Level 3 within the fair value hierarchy. The fair value of these warrants is estimated using a Black-Scholes option pricing model. The valuation incorporates significant unobservable inputs and management judgment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of September 30, 2026, 29,476 of the 29,800 Regulation A Warrants have been exercised for cash for proceeds to the Company of $4,126,639. No Regulation A Warrants were exercised during the nine months ended September 30, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the Regulation A Warrants were estimated using the Black-Scholes model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:50%;border-collapse:collapse;font-size:10pt;border-color:#000000;margin-left:auto;margin-right:auto"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Issue Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;March 10,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation date share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.98%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected warrant life&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;97.81%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;
        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Warrant activity as below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;common share&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;warrants&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted&lt;br/&gt;average exercise&lt;br/&gt;price $&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;Weighted average&lt;br/&gt;remaining life&lt;br/&gt;(years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding as at December 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,636&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;135&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total Warrants outstanding as at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;145,636&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;135&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.16&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The number of warrants outstanding as at the nine months ended September 30, 2026:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td colspan="4" style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:middle;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:middle;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number&lt;br/&gt;exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants issued as part of the IPO&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 15, 2029&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;232&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,712&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,712&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Regulation A Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 10, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;140&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;324&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;324&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 30, 2030 Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle;background-color:#e6efff"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 2, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;155&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,200&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,200&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Series C and D Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2031&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;100&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,400&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,400&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Standby Equity Purchase Agreement and At the market program&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 10, 2025, the Company also announced that it had entered into a standby equity purchase agreement (the "SEPA") with YA II PN, Ltd. ("Yorkville"). Pursuant to the SEPA and subject to the satisfaction of certain conditions, Yorkville was committed to purchase the Company's common shares in increments up to an aggregate gross sales price of $15,000,000 during the 36 months following the date of the SEPA (such shares, the "Shares"). The Shares were to be sold at the Company's option pursuant to the SEPA at 97% of the Market Price (as defined pursuant to the SEPA) and purchases were subject to certain limitations set forth in the SEPA. For the nine months ended September 30, 2026, the Company issued 106,735 common shares pursuant to the SEPA at market prices for gross proceeds of $4,229,823 and net proceeds of $4,102,740. During the nine months ended September 30, 2026, $3,223,980 of the gross proceeds received under the SEPA were held back to partially repay the Company's Yorkville debenture and related interest obligations. The Company and YA II PN, LTD mutually agreed to terminate the SEPA, effective September 11, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 29, 2025, the Company entered into an equity distribution agreement (the "ATM Agreement") with Maxim Group LLC and Yorkville Securities LLC ("Yorkville Securities" and together with Maxim Group LLC, the "Agents") to create an at-the-market equity program (the "ATM"). Under the ATM Agreement, the Company may offer and sell its common shares from time to time through the Agents. The Company agreed to pay the Agents a commission equal to 3% of the gross sales from the sales of the shares pursuant to the ATM Agreement. For the nine months ended September 30, 2026, the Company has issued 1,035,449 common shares as part of the program. The gross proceeds from the issuance were $17,770,248.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplit
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030024703671">At the Company's 2026 Annual General meeting and Special Meeting held on June 3, 2026, the Company's shareholders approved a proposal authorizing the Company's board of directors to effect a consolidation of the common shares at a ratio of up to 50-to-1. Subsequently, the Company's board of directors approved a share consolidation of the Company's common shares on a 50-to-1 basis, which became effective on October 12, 2026.</us-gaap:StockholdersEquityNoteStockSplit>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="0"
      id="F20260321072134998_15"
      unitRef="USD">4172000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="INF"
      id="F20260321072134999_16"
      unitRef="Share">29800</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="0"
      id="F20260321072134999_17"
      unitRef="USD_Per_Share">140</us-gaap:SharesIssuedPricePerShare>
    <mdcx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="0"
      id="F20260321072135000_18"
      unitRef="USD_Per_Share">140</mdcx:ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsGrantsInPeriodWeightedAverageExercisePrice>
    <mdcx:StockPurchaseWarrantsTerm
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      id="Fxbrl_20260323102539545">P5Y</mdcx:StockPurchaseWarrantsTerm>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="0"
      id="F20260321072135000_20"
      unitRef="USD">483020</us-gaap:PaymentsOfStockIssuanceCosts>
    <mdcx:FairValuePerShare
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="0"
      id="F20260321072135001_21"
      unitRef="USD_Per_Share">170</mdcx:FairValuePerShare>
    <mdcx:FairValuePerWarrant
      contextRef="C_20250310to20250310_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="2"
      id="F20260321072135001_22"
      unitRef="USD_Per_Share">131.5</mdcx:FairValuePerWarrant>
    <mdcx:NumberOfWarrantsExercised
      contextRef="C_20260930_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="INF"
      id="F20260321072135005_33"
      unitRef="Share">29476</mdcx:NumberOfWarrantsExercised>
    <mdcx:NumberOfCommonShareWarrantsOutstandingGrantsInPeriod
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="INF"
      id="F20260321072135005_34"
      unitRef="Share">29800</mdcx:NumberOfCommonShareWarrantsOutstandingGrantsInPeriod>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxRegulationAOfferingMember"
      decimals="0"
      id="Fxbrl_20260809151738991"
      unitRef="USD">4126639</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="C_20260101to20260930"
      id="F20260321072135028_76">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:50%;border-collapse:collapse;font-size:10pt;border-color:#000000;margin-left:auto;margin-right:auto"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Issue Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;March 10,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation date share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.98%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected warrant life&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;97.81%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_mdcxMeasurementInputValuationDateSharePriceMember"
      decimals="0"
      id="F20260321072135002_24"
      unitRef="USD_PER_SHARE">170</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputExercisePriceMember"
      decimals="0"
      id="F20260321072135003_26"
      unitRef="USD_PER_SHARE">140</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputExpectedDividendRateMember"
      decimals="2"
      id="F20260321072135003_28"
      unitRef="Percentage">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="F20260321072135004_30"
      unitRef="Percentage">0.0398</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputExpectedTermMember"
      decimals="0"
      id="F20260321072135037_99"
      unitRef="Year">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_20250310_usgaapFinancialInstrumentAxis_mdcxRegulationAWarrantsMember_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputPriceVolatilityMember"
      decimals="2"
      id="F20260321072135005_32"
      unitRef="Percentage">97.81</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <mdcx:ScheduleOfWarrantsContinuityOutstandingAndExercisableTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260809151418948">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;common share&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;warrants&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted&lt;br/&gt;average exercise&lt;br/&gt;price $&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;Weighted average&lt;br/&gt;remaining life&lt;br/&gt;(years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding as at December 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,636&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;135&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total Warrants outstanding as at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;145,636&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;135&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.16&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </mdcx:ScheduleOfWarrantsContinuityOutstandingAndExercisableTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20251231_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="INF"
      id="Fxbrl_20260321163632269_20260321072135029_78"
      unitRef="Share">145636</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mdcx:WeightedAverageExercisePriceOfWarrant
      contextRef="C_20251231_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="0"
      id="Fxbrl_20260321163632269_20260321072135030_81"
      unitRef="USD_Per_Share">135</mdcx:WeightedAverageExercisePriceOfWarrant>
    <mdcx:WeightedAverageRemainingContractualTermOfWarrant
      contextRef="C_20250101to20251231_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      id="Fxbrl_20260321163632269_20260321072135030_80">P4Y10M24D</mdcx:WeightedAverageRemainingContractualTermOfWarrant>
    <mdcx:NumberOfCommonShareWarrantsOutstandingGrantsInPeriod
      contextRef="C_20260101to20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="INF"
      id="F20260321072135031_84"
      unitRef="Share">0</mdcx:NumberOfCommonShareWarrantsOutstandingGrantsInPeriod>
    <mdcx:WeightedAverageExercisePriceWarrantGranted
      contextRef="C_20260101to20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="0"
      id="F20260321072135034_92"
      unitRef="USD_Per_Share">0</mdcx:WeightedAverageExercisePriceWarrantGranted>
    <mdcx:NumberOfCommonShareWarrantsOutstandingExerciseInPeriod
      contextRef="C_20260101to20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="INF"
      id="Fxbrl_20260321164432396_20260321072135032_86"
      unitRef="Share">0</mdcx:NumberOfCommonShareWarrantsOutstandingExerciseInPeriod>
    <mdcx:WeightedAverageExercisePriceWarrantExercise
      contextRef="C_20260101to20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="0"
      id="Fxbrl_20260321164432396_20260321072135035_94"
      unitRef="USD_Per_Share">0</mdcx:WeightedAverageExercisePriceWarrantExercise>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="INF"
      id="F20260321072135031_83"
      unitRef="Share">145636</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mdcx:WeightedAverageExercisePriceOfWarrant
      contextRef="C_20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      decimals="0"
      id="Fxbrl_20260509013754603"
      unitRef="USD_Per_Share">135</mdcx:WeightedAverageExercisePriceOfWarrant>
    <mdcx:WeightedAverageRemainingContractualTermOfWarrant
      contextRef="C_20260101to20260930_usgaapFinancialInstrumentAxis_usgaapWarrantMember"
      id="Fxbrl_20260509013801382">P4Y1M28D</mdcx:WeightedAverageRemainingContractualTermOfWarrant>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_20260101to20260930"
      id="F20260321072135011_50">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td colspan="4" style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:middle;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:middle;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:middle;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;
                    &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number&lt;br/&gt;exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants issued as part of the IPO&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 15, 2029&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;232&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,712&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top;background-color:#e6efff;border-top:0.75pt solid #000000"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,712&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Regulation A Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 10, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;140&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;324&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;324&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 30, 2030 Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle;background-color:#e6efff"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 2, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;155&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,200&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top;background-color:#e6efff"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,200&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25.74%;vertical-align:top"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Series C and D Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:19.34%;vertical-align:middle"&gt;
                    &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2031&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:16.6%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;100&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:23.18%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,400&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="width:15.12%;vertical-align:top"&gt;
                    &lt;p style="text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,400&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <mdcx:ClassOfWarrantOrRightExpiryDate
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantsIssuedAsPartOfIpoMember"
      id="F20260321072135012_51">November 15, 2029</mdcx:ClassOfWarrantOrRightExpiryDate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantsIssuedAsPartOfIpoMember"
      decimals="0"
      id="F20260321072135013_55"
      unitRef="USD_Per_Share">232</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantsIssuedAsPartOfIpoMember"
      decimals="INF"
      id="F20260321072135013_54"
      unitRef="Share">19712</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mdcx:ClassOfWarrantOrRightExercisable
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantsIssuedAsPartOfIpoMember"
      decimals="INF"
      id="Fxbrl_20260324062626887"
      unitRef="Share">19712</mdcx:ClassOfWarrantOrRightExercisable>
    <mdcx:ClassOfWarrantOrRightExpiryDate
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxRegulationAWarrantsMember"
      id="F20260321072135012_52">March 10, 2030</mdcx:ClassOfWarrantOrRightExpiryDate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxRegulationAWarrantsMember"
      decimals="0"
      id="F20260321072135014_57"
      unitRef="USD_Per_Share">140</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxRegulationAWarrantsMember"
      decimals="INF"
      id="F20260321072135014_56"
      unitRef="Share">324</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mdcx:ClassOfWarrantOrRightExercisable
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxRegulationAWarrantsMember"
      decimals="INF"
      id="Fxbrl_20260324062633517"
      unitRef="Share">324</mdcx:ClassOfWarrantOrRightExercisable>
    <mdcx:ClassOfWarrantOrRightExpiryDate
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantWithExpiryDateJune302030WarrantsMember"
      id="F20260321072135013_53">June 2, 2030</mdcx:ClassOfWarrantOrRightExpiryDate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantWithExpiryDateJune302030WarrantsMember"
      decimals="0"
      id="F20260321072135015_59"
      unitRef="USD_Per_Share">155</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantWithExpiryDateJune302030WarrantsMember"
      decimals="INF"
      id="F20260321072135014_58"
      unitRef="Share">45200</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mdcx:ClassOfWarrantOrRightExercisable
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxWarrantWithExpiryDateJune302030WarrantsMember"
      decimals="INF"
      id="Fxbrl_20260324062639233"
      unitRef="Share">45200</mdcx:ClassOfWarrantOrRightExercisable>
    <mdcx:ClassOfWarrantOrRightExpiryDate
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxSeriesCAndDWarrantsMember"
      id="F20260321072135015_60">June 5, 2031</mdcx:ClassOfWarrantOrRightExpiryDate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxSeriesCAndDWarrantsMember"
      decimals="0"
      id="Fxbrl_20251105153503197_20260321072135015_59"
      unitRef="USD_Per_Share">100</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20260930_usgaapStatementEquityComponentsAxis_mdcxSeriesCAndDWarrantsMember"
      decimals="INF"
      id="Fxbrl_20251105153503197_20260321072135014_58"
      unitRef="Share">80400</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mdcx:ClassOfWarrantOrRightExercisable
      contextRef="C_20260101to20260930_usgaapStatementEquityComponentsAxis_mdcxSeriesCAndDWarrantsMember"
      decimals="INF"
      id="Fxbrl_20260324062645731"
      unitRef="Share">80400</mdcx:ClassOfWarrantOrRightExercisable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20250210to20250210_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="F20260321072135009_44"
      unitRef="USD">15000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <mdcx:SharePriceAsPercentageOfMarketPrice
      contextRef="C_20250210to20250210_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember"
      decimals="2"
      id="F20260321072135010_45"
      unitRef="Percent">0.97</mdcx:SharePriceAsPercentageOfMarketPrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fxbrl_20261030183218255"
      unitRef="Share">106735</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="F20260321072135026_70"
      unitRef="USD">4229823</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="F20260321072135026_69"
      unitRef="USD">4102740</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <mdcx:ProceedsFromShareIssuanceUsedToRepayOutstandingDebentures
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fxbrl_20260809154820152"
      unitRef="USD">3223980</mdcx:ProceedsFromShareIssuanceUsedToRepayOutstandingDebentures>
    <mdcx:EquityDistributionAgreementCommissionRate
      contextRef="C_20251229_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember"
      decimals="2"
      id="Fxbrl_20260321182936616"
      unitRef="Percent">0.03</mdcx:EquityDistributionAgreementCommissionRate>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember"
      decimals="INF"
      id="Fxbrl_20260509014444569"
      unitRef="Share">1035449</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20260101to20260930_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember"
      decimals="0"
      id="Fxbrl_20260509014515926"
      unitRef="USD">17770248</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509021028221">
    &lt;div&gt;
      &lt;p style="margin-left:17pt;text-indent:-17.85pt;text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6.&lt;/strong&gt;&#160;&lt;strong&gt;Stock-based compensation &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At September 30, 2026, the Company had in place a stock option plan for employee, non-employee directors, and consultants of the Company (the "Plan"). The Plan provides both for the direct award or sale of shares and for the grant of options to purchase shares. Under the plan, the total number of shares available for options cannot exceed 10% of the Company's issued and outstanding common shares at the time of any grant. The Company is authorized to issue options to employees, non-employee directors and consultants under the plan.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;
        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;On March 30, 2026, the Company issued 19,500 stock options to directors, officers, and employees of the Company. The options are exercisable at $25 per share, expire five years from the grant date, and vest quarterly over a one-year period. On June 3, 2026, the Company issued an additional 41,500 stock options to directors, officers, and employees of the Company. The options are exercisable at $18 per share, expire five years from the grant date, and vest quarterly over a one-year period. On September 4, 2026, the Company issued 29,000 options to directors, officers and employees of the Company. The options are exercisable at $8.53 per share, expire five years from the grant date, and vest quarterly over a one year period. On September 27, 2026, the Company issued 1,000 options to a consultant of the Company. The options are exercisable at $7.50 per share, expire five years from the grant date, and vest quarterly over a one year period. During the three months ended June 30, 2026, the Company accelerated the vesting of all&#160; outstanding options, other than 41,500 options that were granted during the second quarter of 2026. This resulted in additional share-based compensation of&#160; $699,834.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes option transactions for the Plan:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;average&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;exercise price&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;average&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;remaining&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;contractual life&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;(years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;intrinsic value&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at December 31, 2024&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;23,700&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;73.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.18&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;59&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;16,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;149.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.81&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(2,900&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;55.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(150&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;138&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;37,150&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;108.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.06&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;7.5&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercisable at September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;22,650&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;80.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.57&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;35&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Unvested at September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;152&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.18&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;50,100&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;102.72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2.75&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:21.2pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;91,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;16.37&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:21.2pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(900&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;43.91&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;140,200&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;46.76&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.25&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercisable at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;79,075&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;72.59&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.82&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Unvested at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;61,125&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;13.33&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.80&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of September 30, 2026, there were $542,574 of unrecognized stock-based compensation cost related to share options outstanding, which is expected to be recognized over a weighted-average period of 0.80 years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The weighted average grant date fair value of awards for options granted during the nine months ended September 30, 2026, was $10.74. The fair value of options granted was estimated using the Black-Scholes option pricing model, resulting in the following weighted average assumptions for the options granted:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Weighted-average&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.27%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimated life (in years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;129.93%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the three and nine months ended September 30, 2026, stock-based compensation expense was $131,775 and $2,136,908. For the three and nine months ended September 30, 2025, stock-based compensation expense was $852,757 and $1,082,482. Stock-based compensation expense has been reported in the Company's condensed consolidated statements of operations and comprehensive loss within the line items 'general and administrative' expenses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <mdcx:LimitOfOptionsAsPercentageOfSharesOutstanding
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20250325182814380"
      unitRef="Percent">0.10</mdcx:LimitOfOptionsAsPercentageOfSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260330to20260330_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fxbrl_20260509022608290"
      unitRef="Share">19500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260330to20260330_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fxbrl_20260509022617981"
      unitRef="USD_Per_Share">25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20260330to20260330_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      id="Fxbrl_20260509022622751">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20260330to20260330_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      id="Fxbrl_20260509022627134">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260601to20260603_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fxbrl_20260809160528164"
      unitRef="Share">41500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260601to20260603_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fxbrl_20260809160554428"
      unitRef="USD_Per_Share">18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20260601to20260603_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      id="Fxbrl_20260809160601051">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20260601to20260603_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      id="Fxbrl_20260809160608532">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260904to20260904_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fxbrl_20261030030316967"
      unitRef="Share">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260904to20260904_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="2"
      id="Fxbrl_20261030030334359"
      unitRef="USD_Per_Share">8.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20260904to20260904_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      id="Fxbrl_20261030030348303">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20260904to20260904_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      id="Fxbrl_20261030030721911">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxConsultantsMember"
      decimals="0"
      id="Fxbrl_20261030030749110"
      unitRef="Share">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxConsultantsMember"
      decimals="2"
      id="Fxbrl_20261030030815463"
      unitRef="USD_Per_Share">7.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxConsultantsMember"
      id="Fxbrl_20261030030831631">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxConsultantsMember"
      id="Fxbrl_20261030030841095">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260927to20260927_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fxbrl_20260809160619082"
      unitRef="Share">41500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <mdcx:AdditionalShareBasedCompensation
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20261030032638433"
      unitRef="USD">699834</mdcx:AdditionalShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509015400849">
          &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;average&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;exercise price&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;average&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;remaining&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;contractual life&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;(years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;intrinsic value&lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at December 31, 2024&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;23,700&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;73.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.18&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;59&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;16,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;149.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.81&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(2,900&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;55.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(150&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;138&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;37,150&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;108.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.06&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;7.5&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercisable at September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;22,650&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;80.50&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.57&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;35&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Unvested at September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;152&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.18&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;50,100&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;102.72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2.75&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:21.2pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;91,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;16.37&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:21.2pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(900&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;43.91&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;140,200&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;46.76&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.25&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercisable at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;79,075&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;72.59&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.82&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.75pt;padding-left:5.75pt;vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Unvested at September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;61,125&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;13.33&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.80&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20260509021349807_xbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_12"
      unitRef="Share">23700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20241231"
      decimals="2"
      id="Fxbrl_20260509021349807_xbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_15"
      unitRef="USD_Per_Share">73.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20240101to20241231"
      id="Fxbrl_20260509021349807_xbrl_20260509014944168_xbrl_20250324181437312">P4Y2M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20260509021349807_xbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_111"
      unitRef="USD">59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260809160005135_xbrl_20260509015013472_xbrl_20250811142538631"
      unitRef="Share">16500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20250101to20250930"
      decimals="2"
      id="Fxbrl_20260809160005135_xbrl_20260509015013472_xbrl_20250811142601463"
      unitRef="USD_Per_Share">149.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <mdcx:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
      contextRef="C_20250101to20250930"
      id="Fxbrl_20260809160005135_xbrl_20260509015013472_xbrl_20250811142608728">P4Y9M21D</mdcx:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030032727169"
      unitRef="Share">2900</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20250101to20250930"
      decimals="2"
      id="Fxbrl_20261030032740595"
      unitRef="USD_Per_Share">55.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030032731833"
      unitRef="Share">150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20261030032744736"
      unitRef="USD_Per_Share">138</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20250930"
      decimals="0"
      id="Fxbrl_20260509021353733_xbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_12"
      unitRef="Share">37150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20250930"
      decimals="2"
      id="Fxbrl_20260509021353733_xbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_15"
      unitRef="USD_Per_Share">108.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20250101to20250930"
      id="Fxbrl_20260509021353733_xbrl_20260509014944168_xbrl_20250324181437312">P4Y21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20250930"
      decimals="1"
      id="Fxbrl_20260509021353733_xbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_111"
      unitRef="USD">7.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20250930"
      decimals="0"
      id="Fxbrl_20260509021407501_xbrl_20260509015056344_xbrl_20250324180521687_72"
      unitRef="Share">22650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20250930"
      decimals="2"
      id="Fxbrl_20260509021407501_xbrl_20260509015056344_xbrl_20250324180521687_75"
      unitRef="USD_Per_Share">80.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_20250101to20250930"
      id="Fxbrl_20260509021407501_xbrl_20260509015056344_xbrl_20250324180521687_78">P3Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_20250930"
      decimals="0"
      id="Fxbrl_20260509021407501_xbrl_20260509015056344_xbrl_20250324180521687_711"
      unitRef="USD">35</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_20250930"
      decimals="INF"
      id="Fxbrl_20260509021414469_xbrl_20260509015104079_xbrl_20250324180521687_82"
      unitRef="Share">14500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20250930"
      decimals="0"
      id="Fxbrl_20260509021414469_xbrl_20260509015104079_xbrl_20250325103832992"
      unitRef="USD_Per_Share">152</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_20250101to20250930"
      id="Fxbrl_20260509021414469_xbrl_20260509015104079_xbrl_20250325105103101">P4Y2M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_12"
      unitRef="Share">50100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20251231"
      decimals="2"
      id="Fxbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_15"
      unitRef="USD_Per_Share">102.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20250101to20251231"
      id="Fxbrl_20260509014944168_xbrl_20250324181437312">P2Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260509014944168_xbrl_20250324181236791_xbrl_20250324180521687_111"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260509015013472_xbrl_20250811142538631"
      unitRef="Share">91000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20260509015013472_xbrl_20250811142601463"
      unitRef="USD_Per_Share">16.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <mdcx:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509015013472_xbrl_20250811142608728">P4Y8M19D</mdcx:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20251105132756851"
      unitRef="Share">900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20251105132812260"
      unitRef="USD_Per_Share">43.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260509015049128_xbrl_20250324182436535_xbrl_20250324181236791_xbrl_20250324180521687_12"
      unitRef="Share">140200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20260509015049128_xbrl_20250324182436535_xbrl_20250324181236791_xbrl_20250324180521687_15"
      unitRef="USD_Per_Share">46.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509015049128_xbrl_20250324182436535_xbrl_20250324181437312">P4Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260509015049128_xbrl_20250324182436535_xbrl_20250324181236791_xbrl_20250324180521687_111"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260509015056344_xbrl_20250324180521687_72"
      unitRef="Share">79075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20260509015056344_xbrl_20250324180521687_75"
      unitRef="USD_Per_Share">72.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509015056344_xbrl_20250324180521687_78">P3Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260509015056344_xbrl_20250324180521687_711"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_20260930"
      decimals="INF"
      id="Fxbrl_20260509015104079_xbrl_20250324180521687_82"
      unitRef="Share">61125</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20260930"
      decimals="2"
      id="Fxbrl_20260509015104079_xbrl_20250325103832992"
      unitRef="USD_Per_Share">13.33</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509015104079_xbrl_20250325105103101">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260509015104079_xbrl_20250325105245212"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20250324203254745"
      unitRef="USD">542574</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_20260101to20260930"
      id="Fxbrl_20250325135300051">P0Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20250809015123536"
      unitRef="USD_Per_Share">10.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260810163956578">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Weighted-average&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.27%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimated life (in years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;129.93%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="Fxbrl_20260509015239492_xbrl_20250809064019026"
      unitRef="USD_Per_Share">16.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="C_20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="Fxbrl_20260509015239492_xbrl_20250809064050283"
      unitRef="USD_Per_Share">15.33</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="Fxbrl_20260509015239493_xbrl_20250809064053729"
      unitRef="Percent">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="4"
      id="Fxbrl_20250809064056897"
      unitRef="Percent">0.0427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="Fxbrl_20250809064112019">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_20260101to20260930_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="4"
      id="Fxbrl_20260509015239494_xbrl_20250809064109086"
      unitRef="Percent">1.2993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20260812123047230"
      unitRef="USD">131775</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260812123101326"
      unitRef="USD">2136908</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20260812123120147"
      unitRef="USD">852757</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260812123126205"
      unitRef="USD">1082482</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509023016958">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;7.&lt;/strong&gt;&#160;&lt;strong&gt;Related party transactions&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;On October 18, 2023, the Company signed an agreement with RBx Capital, LP (&#x201c;RBx&#x201d;), a family office controlled by the Company&#x2019;s Executive Chairman and CEO, that provides for certain managerial positions to be filled from within RBx. RBx is responsible for the payment and provision of all wages, bonuses, and benefits for these positions. In January 2026, reimbursable salaries paid to RBx pursuant to this agreement were increased to $125,000 per month from $100,000 per month. Reimbursable salaries paid to RBx were $375,000 and $300,000 during the three months ended September 30, 2026, and 2025, respectively. Reimbursable salaries paid to RBx were $1,125,000 and $900,000 during the nine months ended September 30, 2026, and 2025, respectively. Additional expenses of $132,205 and $128,879 were incurred by RBx on behalf of the Company during the three months ended September 30, 2026, and 2025, respectively. Additional expenses of $281,310 and $233,790 were incurred by RBx on behalf of the Company during the nine months ended September 30, 2026, and 2025, respectively. The total amount of accounts payable to RBx was $162,649 and $194,152 as of September 30, 2026, and December 31, 2025, respectively. The reimbursable salaries and additional expenses incurred by RBx on behalf of the Company are included in general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20260101to20260131_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103013900850"
      unitRef="USD">125000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20231018to20231018_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103013907179"
      unitRef="USD">100000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20260701to20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103013923327"
      unitRef="USD">375000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20250701to20250930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103013929064"
      unitRef="USD">300000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20260101to20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014022832"
      unitRef="USD">1125000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20250101to20250930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014029259"
      unitRef="USD">900000</us-gaap:SalariesWagesAndOfficersCompensation>
    <mdcx:RelatedPartyTransactionAdditionalExpenses
      contextRef="C_20260701to20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014129478"
      unitRef="USD">132205</mdcx:RelatedPartyTransactionAdditionalExpenses>
    <mdcx:RelatedPartyTransactionAdditionalExpenses
      contextRef="C_20250701to20250930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014432351"
      unitRef="USD">128879</mdcx:RelatedPartyTransactionAdditionalExpenses>
    <mdcx:RelatedPartyTransactionAdditionalExpenses
      contextRef="C_20260101to20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014205981"
      unitRef="USD">281310</mdcx:RelatedPartyTransactionAdditionalExpenses>
    <mdcx:RelatedPartyTransactionAdditionalExpenses
      contextRef="C_20250101to20250930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014457235"
      unitRef="USD">233790</mdcx:RelatedPartyTransactionAdditionalExpenses>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="C_20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014702612"
      unitRef="USD">162649</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="C_20251231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxRbxCapitalLPMember"
      decimals="0"
      id="Fxbrl_20261103014720469"
      unitRef="USD">194152</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260321105359264">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8.&lt;/strong&gt;&#160;&lt;strong&gt;Fair value measurements&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accounting guidance for fair value establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-left:36pt;text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1: Observable inputs such as quoted prices in active markets;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-left:36pt;text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2: Inputs, other than the quoted prices in active markets that are observable either directly or indirectly; and&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-left:36pt;text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3: Unobservable inputs in which there is little or no market data, or which require the reporting entity to develop its own assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's cash and cash equivalents and restricted cash are classified as Level 1. The fair value of the Company's cash and cash equivalents is determined based on market pricing that is both objective and publicly available. As of September 30, 2026 and December 31, 2025, the fair value of the Company's cash and cash equivalents and restricted cash were $13,094,830 and $8,705,218, respectively. As of September 30, 2026 and December 31, 2025, the Company's cash equivalents are invested in money market funds.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="10" style="vertical-align:bottom;white-space:nowrap;text-align:center;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Level 1&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Level 2&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Level 3&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:27pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,663,521&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,663,521&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-current assets:&lt;br/&gt;Money market funds - Restricted cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,075,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,075,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:52.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,738,596&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,738,596&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="10" style="vertical-align:bottom;white-space:nowrap;width:10%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="10" style="vertical-align:bottom;white-space:nowrap;border-bottom:0.75pt solid #000000;width:10%;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Level 1&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Level 2&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Level 3&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current assets:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:27pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:52.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;&lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company did not reclassify any investments between levels in the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying value of the Company's secured promissory notes described in Note 12 below approximates the fair value since the financial instrument is short-term with a maturity date of November 27, 2027. As of September 30, 2026 and December 31, 2025, the carrying amounts of the Company's other financial instruments, which include cash and cash equivalents and restricted cash, accounts payable and accrued expenses approximate fair values because of their short-term maturities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_20260930"
      decimals="0"
      id="Fxbrl_20260321111218190"
      unitRef="USD">13094830</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_20251231"
      decimals="0"
      id="Fxbrl_20260321111227246"
      unitRef="USD">8705218</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260809161332878">
        &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="10" style="vertical-align:bottom;white-space:nowrap;text-align:center;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Level 1&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Level 2&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Level 3&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:27pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,663,521&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,663,521&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-current assets:&lt;br/&gt;Money market funds - Restricted cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,075,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,075,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:52.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,738,596&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,738,596&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="10" style="vertical-align:bottom;white-space:nowrap;width:10%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="10" style="vertical-align:bottom;white-space:nowrap;border-bottom:0.75pt solid #000000;width:10%;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Level 1&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Level 2&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Level 3&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:10%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current assets:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:27pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:52.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double #000000;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,812,918&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double #000000;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112324586_20260321050257311_4"
      unitRef="USD">3663521</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112324586_20260321050257311_5"
      unitRef="USD">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112324586_20260321050257311_6"
      unitRef="USD">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20260930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112324586_20260321050257312_7"
      unitRef="USD">3663521</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20261030014356139_xbrl_20260321112324586_20260321050257311_4"
      unitRef="USD">8075075</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20261030014356139_xbrl_20260321112324586_20260321050257311_5"
      unitRef="USD">0</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20261030014356139_xbrl_20260321112324586_20260321050257311_6"
      unitRef="USD">0</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="C_20260930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20261030014356139_xbrl_20260321112324586_20260321050257312_7"
      unitRef="USD">8075075</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257311_4"
      unitRef="USD">11738596</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257311_5"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20260930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257311_6"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20260930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257312_7"
      unitRef="USD">11738596</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112327479_20260321050257311_4"
      unitRef="USD">7812918</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112327479_20260321050257311_5"
      unitRef="USD">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112327479_20260321050257311_6"
      unitRef="USD">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20251231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fxbrl_20260321112327479_20260321050257312_7"
      unitRef="USD">7812918</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257312_12"
      unitRef="USD">7812918</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257312_13"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20251231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257313_14"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20251231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="0"
      id="F20260321050257313_15"
      unitRef="USD">7812918</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260321102720325">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;9.&lt;/strong&gt;&#160;&lt;strong&gt;Commitments and contingencies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div&gt;
            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Commitments&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As part of the acquisition of Antev, the Company may be required to make future payments contingent on the achievement of specified milestones. These potential payments represent a commitment and may result in future cash outflows. As these milestones conditions are not considered probable, the Company has not recognized liability related to the contingent consideration.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the terms of the Antev Acquisition, the Company acquired 98.60% of ownership in Antev including all the assets and its In-Process Research and Development (IPR&amp;amp;D) - Teverelix. There was additional contingent consideration based on the following development milestones of the IPR&amp;amp;D:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Phases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent Consideration agreed for&lt;br/&gt;Antev shares acquired through issue of&lt;br/&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent Consideration agreed&lt;br/&gt;for Antev shares acquired by cash&lt;br/&gt;payment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i) Advanced Prostate Cancer - Phase 2 success or registration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$100 per common share issued&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.47 per Antev share (pro rata interest in $5,333,200)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)Acute Urinary Retention Prevention - Phase 2 success or registration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$375 per common share issued&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.52 per Antev share (pro rata interest in $19,999,500)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iii) FDA NDA approval - Hormone therapy for prostate cancer&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Up to $20,000,000 (subject to pro rata reduction)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.52 per Antev share (pro rata interest in $20,000,000)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iv) FDA NDA approval - AUR prevention&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Up to $20,000,000 (subject to pro rata reduction)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.52 per Antev share (pro rata interest in $20,000,000)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As described in Note 10, the Company entered into a Co-Development and License Agreement with Pfizer Inc. ("Pfizer"). Under the agreement the pharmaceutical company is eligible to receive development and regulatory milestone payments upon the achievement of specified clinical and regulatory events across multiple indications, as well as sales-based milestone payments upon the achievement of specified annual and cumulative net sales threshold. Pfizer is eligible to receive tiered royalties on annual net sales of products on a product-by-product and country-by-country basis during the royalty term. The aggregate potential, regulatory and sales milestone payments under Co-Development and License Agreement exceed $1.0 billion, assuming achievement of all applicable milestones across multiple indications and commercial thresholds.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of September 30, 2026, the Company had no other long-term commitments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Contingencies &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the ordinary course of business, from time to time, the Company may be involved in various claims related to operations, rights, commercial, employment or other claims. Although such matters cannot be predicted with certainty, management does not consider the Company's exposure to such claims to be material to these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember"
      decimals="4"
      id="Fxbrl_20260812173234560"
      unitRef="Percent">0.986</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260812152017209">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Phases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent Consideration agreed for&lt;br/&gt;Antev shares acquired through issue of&lt;br/&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top;background-color:#e6efff;white-space:nowrap"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent Consideration agreed&lt;br/&gt;for Antev shares acquired by cash&lt;br/&gt;payment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i) Advanced Prostate Cancer - Phase 2 success or registration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$100 per common share issued&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.47 per Antev share (pro rata interest in $5,333,200)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)Acute Urinary Retention Prevention - Phase 2 success or registration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$375 per common share issued&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.52 per Antev share (pro rata interest in $19,999,500)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iii) FDA NDA approval - Hormone therapy for prostate cancer&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Up to $20,000,000 (subject to pro rata reduction)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.52 per Antev share (pro rata interest in $20,000,000)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:33.82%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iv) FDA NDA approval - AUR prevention&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.48%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:32.86%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Up to $20,000,000 (subject to pro rata reduction)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:1.5%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:30.34%;vertical-align:top;background-color:#e6efff"&gt;
                        &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.52 per Antev share (pro rata interest in $20,000,000)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_20260930_mdcxBusinessCombinationConsiderationTransferredEquityInterestTypeAxis_usgaapCommonStockMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesOneMember"
      decimals="0"
      id="Fxbrl_20260812151036268"
      unitRef="USD_Per_Share">100</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesOneMember"
      decimals="2"
      id="Fxbrl_20260812151114782"
      unitRef="USD_Per_Share">1.47</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_20260930_mdcxBusinessCombinationConsiderationTransferredEquityInterestTypeAxis_usgaapCommonStockMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesOneMember"
      decimals="0"
      id="Fxbrl_20260812151133117"
      unitRef="USD">5333200</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_20260930_mdcxBusinessCombinationConsiderationTransferredEquityInterestTypeAxis_usgaapCommonStockMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesTwoMember"
      decimals="0"
      id="Fxbrl_20260812151240084"
      unitRef="USD_Per_Share">375</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesTwoMember"
      decimals="2"
      id="Fxbrl_20260812151306717"
      unitRef="USD_Per_Share">5.52</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesTwoMember"
      decimals="0"
      id="Fxbrl_20260812151323991"
      unitRef="USD">19999500</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_20260930_srtRangeAxis_srtMaximumMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesThreeMember"
      decimals="0"
      id="Fxbrl_20260812151342260"
      unitRef="USD">20000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesThreeMember"
      decimals="2"
      id="Fxbrl_20260812151537933"
      unitRef="USD_Per_Share">5.52</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesThreeMember"
      decimals="0"
      id="Fxbrl_20260812151558038"
      unitRef="USD">20000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_20260930_srtRangeAxis_srtMaximumMember_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesFourMember"
      decimals="0"
      id="Fxbrl_20260812151629135"
      unitRef="USD">20000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesFourMember"
      decimals="2"
      id="Fxbrl_20260812151703255"
      unitRef="USD_Per_Share">5.52</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_20260930_usgaapBusinessAcquisitionAxis_mdcxAntevLimitedMember_usgaapContingentConsiderationByTypeAxis_mdcxContingentConsiderationPhasesFourMember"
      decimals="0"
      id="Fxbrl_20260812151735397"
      unitRef="USD">20000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <mdcx:AggregatePotentialMilestonePayments
      contextRef="C_20260930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember"
      decimals="-8"
      id="Fxbrl_20261030045634051"
      unitRef="USD">1000000000</mdcx:AggregatePotentialMilestonePayments>
    <us-gaap:AssetAcquisitionTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030043702051">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10. Acquisition of In-process research and development asset ("IPR&amp;amp;D")&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 2, 2026, the Company entered into a co-development and license agreement (the "Agreement") with Pfizer (the "Licensor") relating to CD228V, an investigational antibody-drug conjugate currently under clinical development. Under the Agreement, the Company acquired certain rights to develop, manufacture and commercialize CD228V and related products, together with certain regulatory, clinical and development-related materials. The acquired materials primarily consist of materials to support ongoing clinical and development activities. No material amount of inventory was acquired as part of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determined that the transaction represents an asset acquisition and that the acquired CD228V rights constitute in-process research and development ("IPR&amp;amp;D") with no alternative future use. Accordingly, the acquisition cost attributable to the acquired IPR&amp;amp;D was recognized in expense in the unaudited condensed consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the Agreement, the Company was required to make a one-time, non-refundable and non-creditable upfront payment of $12.0 million on September 2, 2026. The Company recognized the applicable acquisition cost as acquired IPR&amp;amp;D expense during the three and nine months ended September 30, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In connection with the Agreement, the Licensor paid the Company a one-time, non-refundable and non-creditable $2.0 million development funding payment, which is required to be used to fund development activities for CD228V under the development plan. As of September 30, 2026, the Company had incurred qualifying costs in excess of the development funding received. Accordingly, the Company recognized the $2.0 million payment as a reduction of the related acquired IPR&amp;amp;D expense. As a result, the Company recognized net acquired IPR&amp;amp;D expense of $10.0 million in the unaudited condensed consolidated statement of operations and comprehensive loss during the three and nine months ended September 30, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Agreement provides for an additional payment of $15.0 million to be made on the first anniversary of the effective date of the agreement September 2, 2027, unless the Company exercises its right to terminate the Agreement by providing written notice of termination by June 4, 2027, provided the first patient has not yet been dosed in the Phase 1 clinical trial. If the first patient is dosed before June 4, 2027, the Company would instead be required to provide at least 90 days' notice before such dosing occurs to terminate the Agreement. If the Company exercises its termination right, the rights and obligations under the Agreement cease. As the Company's ability to terminate the Agreement is within the Company's control, no liability for the $15.0 million payment was recognized as of September 30, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Agreement also provides for additional payments upon the achievement of certain development, regulatory and sales milestones and royalties on future sales of licensed products. As of September 30, 2026, the applicable events triggering the development milestone payments had not occurred and no related liability was recognized as noted in Note 9, Commitments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="C_20260902to20260902_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember"
      decimals="-5"
      id="Fxbrl_20261030043737534"
      unitRef="USD">12000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <mdcx:DevelopmentFundingPaymentReceived
      contextRef="C_20260101to20260930_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember"
      decimals="-5"
      id="Fxbrl_20261030043847843"
      unitRef="USD">2000000</mdcx:DevelopmentFundingPaymentReceived>
    <mdcx:DevelopmentFundingPaymentReceived
      contextRef="C_20260101to20260930_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember"
      decimals="-5"
      id="Fxbrl_20261102115502564"
      unitRef="USD">2000000</mdcx:DevelopmentFundingPaymentReceived>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260101to20260930_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember"
      decimals="-5"
      id="Fxbrl_20261030043940108"
      unitRef="USD">10000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="C_20270902to20270902_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="-5"
      id="Fxbrl_20261030044023060"
      unitRef="USD">15000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="C_20270902to20270902_usgaapAssetAcquisitionAxis_mdcxCd228vRightsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_mdcxPfizerMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="-5"
      id="Fxbrl_20261102115012304"
      unitRef="USD">15000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509025046115">
    &lt;div&gt;
      &lt;p style="margin-left:17pt;text-indent:-17.85pt;text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;11.&lt;/strong&gt;&#160;&lt;strong&gt;Segment reporting&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker ("CODM") in deciding how to allocate resources to an individual segment and in assessing performance. The Company manages the business activities on a consolidated basis and operates as one reportable segment that constitutes all of the consolidated entity, which is the business of advancing the clinical development program of the Company's product, while opportunistically identifying, evaluating, and acquiring accretive assets, properties or businesses. The Company's CODM is its Chief Executive Officer. The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM uses consolidated net loss to measure segment loss, allocate resources and assess performance. Additionally, the CODM reviews cash forecast models to determine where the Company will invest in planned research and development activities. As the Company's operations are comprised of a single reporting segment, the segment assets are reflected on the accompanying condensed consolidated balance sheet as Total Assets. Segment asset information is not used by the CODM to allocate resources.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span id="page_24"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The following table is representative of the significant expense categories regularly provided to the CODM when managing the Company's single reporting segment. A reconciliation to consolidated operating expenses as the Company's single segment operating loss for the three and nine months ended September 30, 2026 and 2025 is included in the table below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%"&gt;

            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="2" style="width:36%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Three Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="2" style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Nine Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Research and development expenses:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;SkinJect&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical, manufacturing and regulatory activities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;464,223&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,114,470&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,475,511&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,568,401&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services and intellectual property&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,558&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,092&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;196,785&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,770&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Teverelix&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical, manufacturing and regulatory activities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,389,137)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,238&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,460,885&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,238&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services and intellectual property&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,358&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,699&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;CD228V&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services and intellectual property&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,649&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,649&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,708,130&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;519,983&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,235,336&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,395,152&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;white-space:nowrap;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total research and development expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,952,780&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,684,783&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;9,564,865&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5,130,561&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total general and administrative expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,507,476&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5,024,082&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,971,257&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12,720,666&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total In-Process Research and Development (IPR&amp;amp;D) expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,000,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8,717,475&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,000,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8,717,475&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total operating expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,460,256&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;15,426,340&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;34,536,122&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;26,568,702&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Other income (expense):&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income (expense), net&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(712,652)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,572&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,236,441)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75,442&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on SEPA settlements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(157,721)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(127,083)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(157,721)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value of debentures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(383,823)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(583,823)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on extinguishment of debentures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25,000)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25,000)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total other income (expense)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(712,652)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(554,972)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(1,363,524)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(691,102)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net loss for the period&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(15,172,908)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(15,981,312)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(35,899,646)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(27,259,804)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260812173738166"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260812165504668">
        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%"&gt;

            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="2" style="width:36%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Three Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="2" style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Nine Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Research and development expenses:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;SkinJect&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical, manufacturing and regulatory activities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;464,223&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,114,470&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,475,511&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,568,401&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services and intellectual property&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,558&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,092&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;196,785&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,770&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Teverelix&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical, manufacturing and regulatory activities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,389,137)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,238&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,460,885&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,238&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services and intellectual property&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,358&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115,699&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;CD228V&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:24%;padding-right:5.4pt;padding-left:41.4pt;vertical-align:top;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services and intellectual property&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,649&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,649&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,708,130&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;519,983&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,235,336&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,395,152&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;white-space:nowrap;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total research and development expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,952,780&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,684,783&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;9,564,865&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5,130,561&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total general and administrative expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,507,476&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5,024,082&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,971,257&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12,720,666&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total In-Process Research and Development (IPR&amp;amp;D) expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,000,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8,717,475&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,000,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8,717,475&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total operating expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,460,256&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;15,426,340&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;34,536,122&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;26,568,702&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Other income (expense):&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income (expense), net&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(712,652)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,572&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,236,441)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75,442&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on SEPA settlements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(157,721)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(127,083)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(157,721)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value of debentures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(383,823)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(583,823)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on extinguishment of debentures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25,000)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;border-bottom:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25,000)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total other income (expense)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(712,652)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(554,972)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(1,363,524)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(691,102)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;padding-left:3pt;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net loss for the period&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:22%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(15,172,908)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:11%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(15,981,312)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(35,899,646)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:18%;vertical-align:top;border-bottom:0.75pt solid #000000;padding-right:5.4pt;padding-left:5.4pt;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(27,259,804)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260701to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812163638895"
      unitRef="USD">464223</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250701to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812163817879"
      unitRef="USD">1114470</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260101to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812163821574"
      unitRef="USD">2475511</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250101to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812163826824"
      unitRef="USD">3568401</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260701to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164137234_xbrl_20260812163638895"
      unitRef="USD">51558</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250701to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164137234_xbrl_20260812163817879"
      unitRef="USD">49092</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260101to20260930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164137234_xbrl_20260812163821574"
      unitRef="USD">196785</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250101to20250930_deiLegalEntityAxis_mdcxSkinjectIncMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164137234_xbrl_20260812163826824"
      unitRef="USD">165770</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260701to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812164139513_xbrl_20260812163638895"
      unitRef="USD">-1389137</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250701to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812164139513_xbrl_20260812163817879"
      unitRef="USD">1238</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260101to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812164139513_xbrl_20260812163821574"
      unitRef="USD">2460885</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250101to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxClinicalManufacturingAndRegulatoryActivitiesMember"
      decimals="0"
      id="Fxbrl_20260812164139513_xbrl_20260812163826824"
      unitRef="USD">1238</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260701to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164141327_xbrl_20260812163638895"
      unitRef="USD">37358</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250701to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164141327_xbrl_20260812163817879"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260101to20260930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164141327_xbrl_20260812163821574"
      unitRef="USD">115699</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250101to20250930_deiLegalEntityAxis_mdcxTeverelixMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20260812164141327_xbrl_20260812163826824"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260701to20260930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20261030095222703_xbrl_20260812164141327_xbrl_20260812163638895"
      unitRef="USD">80649</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250701to20250930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20261030095222703_xbrl_20260812164141327_xbrl_20260812163817879"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20260101to20260930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20261030095222703_xbrl_20260812164141327_xbrl_20260812163821574"
      unitRef="USD">80649</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="C_20250101to20250930_deiLegalEntityAxis_mdcxCd228vRightsMember_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember_usgaapCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_mdcxProfessionalServicesAndIntellectualPropertyMember"
      decimals="0"
      id="Fxbrl_20261030095222703_xbrl_20260812164141327_xbrl_20260812163826824"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164145506_xbrl_20260812163638895"
      unitRef="USD">2708130</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164145506_xbrl_20260812163817879"
      unitRef="USD">519983</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164145506_xbrl_20260812163821574"
      unitRef="USD">4235336</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164145506_xbrl_20260812163826824"
      unitRef="USD">1395152</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164147650_xbrl_20260812163638895"
      unitRef="USD">1952780</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164147650_xbrl_20260812163817879"
      unitRef="USD">1684783</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164147650_xbrl_20260812163821574"
      unitRef="USD">9564865</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164147650_xbrl_20260812163826824"
      unitRef="USD">5130561</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164149201_xbrl_20260812163638895"
      unitRef="USD">2507476</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164149201_xbrl_20260812163817879"
      unitRef="USD">5024082</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164149201_xbrl_20260812163821574"
      unitRef="USD">14971257</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164149201_xbrl_20260812163826824"
      unitRef="USD">12720666</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030100852479_xbrl_20260812164149201_xbrl_20260812163638895"
      unitRef="USD">10000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030100852479_xbrl_20260812164149201_xbrl_20260812163817879"
      unitRef="USD">8717475</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030100852479_xbrl_20260812164149201_xbrl_20260812163821574"
      unitRef="USD">10000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030100852479_xbrl_20260812164149201_xbrl_20260812163826824"
      unitRef="USD">8717475</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:OperatingExpenses
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164150832_xbrl_20260812163638895"
      unitRef="USD">14460256</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164150832_xbrl_20260812163817879"
      unitRef="USD">15426340</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164150832_xbrl_20260812163821574"
      unitRef="USD">34536122</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164150832_xbrl_20260812163826824"
      unitRef="USD">26568702</us-gaap:OperatingExpenses>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164155160_xbrl_20260812163638895"
      unitRef="USD">-712652</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164155160_xbrl_20260812163817879"
      unitRef="USD">11572</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164155160_xbrl_20260812163821574"
      unitRef="USD">-1236441</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164155160_xbrl_20260812163826824"
      unitRef="USD">75442</us-gaap:InterestIncomeExpenseNet>
    <mdcx:GainLossOnSettlements
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164158430_xbrl_20260812163638895"
      unitRef="USD">0</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164158430_xbrl_20260812163817879"
      unitRef="USD">-157721</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164158430_xbrl_20260812163821574"
      unitRef="USD">-127083</mdcx:GainLossOnSettlements>
    <mdcx:GainLossOnSettlements
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164158430_xbrl_20260812163826824"
      unitRef="USD">-157721</mdcx:GainLossOnSettlements>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164202863_xbrl_20260812163817879"
      unitRef="USD">0</mdcx:ChangeInFairValueOfDebentures>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164202863_xbrl_20260812163821574"
      unitRef="USD">-383823</mdcx:ChangeInFairValueOfDebentures>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030113707264"
      unitRef="USD">0</mdcx:ChangeInFairValueOfDebentures>
    <mdcx:ChangeInFairValueOfDebentures
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164202863_xbrl_20260812163826824"
      unitRef="USD">-583823</mdcx:ChangeInFairValueOfDebentures>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030113921334"
      unitRef="USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030113649472_xbrl_20260812164202863_xbrl_20260812163817879"
      unitRef="USD">-25000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030113649472_xbrl_20260812164202863_xbrl_20260812163821574"
      unitRef="USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20261030113649472_xbrl_20260812164202863_xbrl_20260812163826824"
      unitRef="USD">-25000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164205057_xbrl_20260812163638895"
      unitRef="USD">-712652</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164205057_xbrl_20260812163817879"
      unitRef="USD">-554972</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164205057_xbrl_20260812163821574"
      unitRef="USD">-1363524</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164205057_xbrl_20260812163826824"
      unitRef="USD">-691102</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ProfitLoss
      contextRef="C_20260701to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164206802_xbrl_20260812163638895"
      unitRef="USD">-15172908</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250701to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164206802_xbrl_20260812163817879"
      unitRef="USD">-15981312</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20260101to20260930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164206802_xbrl_20260812163821574"
      unitRef="USD">-35899646</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20250101to20250930_srtConsolidationItemsAxis_usgaapOperatingSegmentsMember"
      decimals="0"
      id="Fxbrl_20260812164206802_xbrl_20260812163826824"
      unitRef="USD">-27259804</us-gaap:ProfitLoss>
    <us-gaap:LongTermDebtTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030113605524">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12. Debentures and Secured Promissory Notes&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 17, 2025, the Company entered into a securities purchase agreement with Yorkville to issue a debenture with the principal amount of $8,000,000 issued at a discount of $633,707 for proceeds of approximately $7,366,293. Interest accrued on the outstanding principal amount of the debenture at an annual rate of 8%, subject to a potential increase to 18% per annum upon the occurrence of certain events of default. The debenture had a maturity date of September 17, 2026, and was to be repaid using proceeds from the SEPA; however, on May 27, 2026, the Company used part of the proceeds from the issuance of the Secured Promissory Notes (as defined herein) to repay and extinguish the outstanding balance and accrued interest owing on the debenture.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The debenture was initially recorded at fair value, based on the discounted proceeds. Subsequently, the Company accounted for the debenture at amortized cost using the effective interest rate method, resulting in accretion expense of $374,712 for the nine months ended September 30, 2026. The effective interest rate calculated was 32.75% as of the repayment date. On May 27, 2026, the Company repaid the outstanding principal balance of $2,343,778 related to the Yorkville debenture, together with accrued interest of $135,664, using proceeds received from the issuance of the Secured Promissory Notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 27, 2026, the Company entered into a Note Purchase Agreement with Streeterville Capital, LLC ("Streeterville"), pursuant to which the Company issued two secured promissory notes with aggregate principal amounts of $22,864,225. The first promissory note ("Note A") was issued with a face value of $12,864,225 and a purchase price of $12,000,000, resulting in an issue discount of $864,225. The second promissory note ("Note B") was issued with a principal amount of $10,000,000. Note A bears interest at 8.75% per annum compounded daily and Note B bears interest at 5.0% per annum compounded daily. Both promissory notes mature on November 27, 2027.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Secured Promissory Notes are secured by a first-ranking security interest over substantially all assets of the Company. Guarantees are provided by the Company's subsidiaries.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company evaluated the transaction under ASC 470-50, Debt Modifications and Extinguishments, and determined that the issuance of the Streeterville promissory notes and repayment of the Yorkville debenture should be accounted for as an extinguishment of debt. Accordingly, the carrying amount of the Yorkville debenture was derecognized upon settlement, and the newly issued promissory notes were recognized as new debt instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company initially recorded the Note A and Note B ("promissory notes") at fair value based on the proceeds received, net of directly attributable debt issuance costs. Subsequently, the Company accounts for the promissory notes at amortized cost using the effective interest method. Debt issuance costs are amortized over the contractual life of the respective promissory notes. The Company incurred $615,000 in debt issuance cost related to the promissory notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Note A permits the lender to require monthly redemptions beginning on the seventh month following the issuance, subject to the terms of the agreement. Beginning on the seventh month following the issuance date, the lender has the right to require monthly redemptions of up to $500,000 per month plus make-whole interest calculated as if the redeemed amount had remained outstanding until maturity. If the Company fails to satisfy a redemption notice within the required period, the outstanding balance is increased by 20% of the applicable redemption amount. In addition, beginning on the sixth month following the issuance date, both Note A and Note B permit the lender to require limited redemptions of up to 5% of the cumulative daily dollar trading volume during specified redemption windows when the Company's common shares trade at least 15% above the defined Minimum Price per the agreement. Such limited redemptions are payable at 110% of the applicable redemption amount.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Both Note A and Note B contain customary trigger event and event of default provisions, including payment defaults, insolvency events, delisting determinations and specified corporate transactions. Upon the occurrence of trigger events, the lender may increase the outstanding balance by 5% for certain minor trigger events or 15% for certain major trigger events, subject to contractual limitations. Following an event of default, the lender may accelerate repayment and default interest may accrue at a rate of up to 18% per annum, subject to applicable law.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;In connection with Note B, $10,000,000 of the proceeds were deposited into a restricted deposit account maintained pursuant to a Deposit Account Control Agreement. The lender has control rights over the account upon the occurrence of specified trigger events and may direct the disposition of funds in the account. Under certain circumstances, amounts outstanding under Note B may be exchanged into additional Note A borrowings. Specifically, for each $2.0 million of Note A principal repaid, up to $1.0 million of the outstanding Note B balance may be exchanged into a new Note A advance, subject to the conditions set out in the financing agreements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company entered into a Note exchange agreement with the lender on September 1, 2026. The Company exchanged $2,000,000 of Note B borrowings to a separate Note A-2 borrowing. Upon execution of the exchange the Note A-2 was issued at a face value of $2,139,037 and a purchase price of $2,000,000, resulting in an issuance discount of $139,037. Note A-2 bears interest of 8.75% per annum compounded daily and matures at the same time as Note A and B above on November 27, 2027. Upon the exchange, the $2,000,000 related to Note A-2 was no longer subject to the restrictions applicable to Note B.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In connection with the exchange agreement, a side letter was signed that required the Company to make a mandatory prepayment upon receipt of proceeds from certain equity fundraising or other financing transactions. The required prepayment is equal to the lesser of 25% of the gross proceeds from the applicable financing transaction and the aggregate outstanding balance of the A Notes and is payable within two trading days of receipt of the proceeds. The lender may determine the outstanding A Note against which the mandatory prepayment is applied. As at September 30, 2026 the Company has repaid $860,680 of the Note A principal based on the financing proceeds received.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company evaluated the exchange transaction under ASC 470-50, Debt Modification and Extinguishment and determined that the exchange of Note B to Note A-2 should be accounted for as a debt modification. Accordingly, the carrying amount of the modified portion of Note A and Note B was carried forward and adjusted for the effects of the modification. The Company incurred $7,411 in debt issuance cost related to the promissory notes exchange which was expensed during the nine months ended September 30, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Note A-2 permits the lender to require monthly redemptions beginning December 27, 2026, subject to the terms of the agreement. The lender has the right to require monthly redemptions of up to $100,000 per month plus make-whole interest calculated as if the redeemed amount had remained outstanding until maturity. If the Company fails to satisfy a redemption notice within the required period, the outstanding balance is increased by 20% of the applicable redemption amount. In addition, beginning on November 27, 2026 Note A-2 permits the lender to require limited redemptions of up to 5% of the cumulative daily dollar trading volume during specified redemption windows when the Company's common shares trade at least 15% above the defined Minimum Price per the agreement. Such limited redemptions are payable at 110% of the applicable redemption amount.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Similar to Note A and Note B, Note A-2 contains customary trigger event and event of default provisions, including payment defaults, insolvency events, delisting determinations and specified corporate transactions. Upon the occurrence of trigger events, the lender may increase the outstanding balance by 5% for certain minor trigger events or 15% for certain major trigger events, subject to contractual limitations. Following an event of default, the lender may accelerate repayment, and default interest may accrue at a rate of up to 18% per annum, subject to applicable law.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at September 30, 2026, the Company was in compliance with the terms and covenants of all the notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company evaluated the embedded features contained within the promissory notes, and concluded that certain features would require bifurcation under ASC 815; however, the fair value of such features was determined to be de minimis. Accordingly, no embedded derivative liability was recorded as of September 30, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debenture issued on September 17, 2025:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net balance as at December 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,245,543&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repayment of new debenture&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,180,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest accretion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,712&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest payment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(96,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;border-color:#000000;font-size:10pt;margin-bottom:0pt;margin-top:0pt"&gt;

                  &lt;tr style="background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:84%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Ending balance as of May 27, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:1%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:12%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;2,343,778&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;width:84%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Repayment of Yorkville debenture&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;margin-top:0pt;margin-bottom:0pt;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:right;margin-top:0pt;margin-bottom:0pt;width:12%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(2,343,778&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;margin-top:0pt;margin-bottom:0pt;width:2%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:84%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Ending balance as of September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:1%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:12%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Note A and Note A-2&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Principal of Note A and Note A-2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;15,003,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Discount on debt&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(1,003,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Debt issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(349,091&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Repayment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(860,680&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest accretion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;397,935&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Ending balance&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;13,188,164&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest Payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;403,726&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Note B issued on May 27, 2026:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Principal of Note B&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exchange to Note A-2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Debt issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(265,909&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest accretion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;63,906&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Ending balance&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;7,797,997&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest Payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;169,870&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of September 30, 2026, total accrued interest related to the promissory notes was $573,596. The interest is payable at maturity or upon redemption of the principal. Of the total accrued interest, $289,710 was included in the current portion of interest payable on secured promissory notes and $283,886 was included in the non-current portion of interest payable on secured promissory notes on the condensed consolidated balance sheet, with the corresponding amounts recognized in interest expense in the condensed consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="C_20250901to20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="F20260321061347344_8"
      unitRef="USD">8000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <mdcx:DebtIssuanceDiscount
      contextRef="C_20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fxbrl_20260321160743159"
      unitRef="USD">633707</mdcx:DebtIssuanceDiscount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_20250901to20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fxbrl_20260321160819556"
      unitRef="USD">7366293</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="2"
      id="F20260321061347344_10"
      unitRef="Percent">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="C_20250901to20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="2"
      id="F20260321061347345_11"
      unitRef="Percent">0.18</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_20250901to20250917_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      id="F20260321061347345_12">2026-09-17</us-gaap:DebtInstrumentMaturityDate>
    <mdcx:ConvertibleDebtAccretionExpense
      contextRef="C_20260101to20260930_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="F20260321061347347_23"
      unitRef="USD">374712</mdcx:ConvertibleDebtAccretionExpense>
    <mdcx:EffectiveInterestRateOnDebt
      contextRef="C_20260101to20260930_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="4"
      id="Fxbrl_20260321161504817"
      unitRef="Percent">0.3275</mdcx:EffectiveInterestRateOnDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20260501to20260527_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fxbrl_20260810103130553"
      unitRef="USD">2343778</us-gaap:RepaymentsOfDebt>
    <mdcx:AccruedInterestRepaid
      contextRef="C_20260501to20260527_usgaapTypeOfArrangementAxis_mdcxSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fxbrl_20260810103316307"
      unitRef="USD">135664</mdcx:AccruedInterestRepaid>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_20260501to20260527_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810110719057"
      unitRef="USD">22864225</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810110742939"
      unitRef="USD">12864225</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810110804602"
      unitRef="USD">12000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810110852840"
      unitRef="USD">864225</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810110825087"
      unitRef="USD">10000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="4"
      id="Fxbrl_20260810111030162"
      unitRef="Percent">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="3"
      id="Fxbrl_20260810111022825"
      unitRef="Percent">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_20260501to20260527_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      id="Fxbrl_20260810111132411">2027-11-27</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_20260501to20260527_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810111602099"
      unitRef="USD">615000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <mdcx:DebtInstrumentRedemptionLimitAmount
      contextRef="C_20260527_srtRangeAxis_srtMaximumMember_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260812143050726"
      unitRef="USD">500000</mdcx:DebtInstrumentRedemptionLimitAmount>
    <mdcx:DebtDefaultBalanceIncreasePercentage
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20260812154444764"
      unitRef="Percent">0.20</mdcx:DebtDefaultBalanceIncreasePercentage>
    <mdcx:DebtInstrumentVolumeBasedRedemptionPercentageLimit
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20260812154510515"
      unitRef="Percent">0.05</mdcx:DebtInstrumentVolumeBasedRedemptionPercentageLimit>
    <mdcx:DebtInstrumentCovenantSharePriceThresholdPercentage
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20260812154749211"
      unitRef="Percent">0.15</mdcx:DebtInstrumentCovenantSharePriceThresholdPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20260812154846305"
      unitRef="Percent">1.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault
      contextRef="C_20260501to20260527_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      id="Fxbrl_20260812114904600">Upon the occurrence of trigger events, the lender may increase the outstanding balance by 5% for certain minor trigger events or 15% for certain major trigger events, subject to contractual limitations. Following an event of default, the lender may accelerate repayment and default interest may accrue at a rate of up to 18% per annum, subject to applicable law.</us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember"
      decimals="0"
      id="Fxbrl_20260812142123073"
      unitRef="USD">10000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <mdcx:DebtInstrumentExchangeThresholdAmount
      contextRef="C_20260501to20260527_usgaapDebtInstrumentAxis_mdcxNoteAMember"
      decimals="-5"
      id="Fxbrl_20260812155856621"
      unitRef="USD">2000000</mdcx:DebtInstrumentExchangeThresholdAmount>
    <mdcx:DebtInstrumentMaximumExchangeLimitAmount
      contextRef="C_20260527_usgaapDebtInstrumentAxis_mdcxNoteBMember"
      decimals="-5"
      id="Fxbrl_20260812155825869"
      unitRef="USD">1000000</mdcx:DebtInstrumentMaximumExchangeLimitAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261102105707285"
      unitRef="USD">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030102550358"
      unitRef="USD">2139037</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030102534846"
      unitRef="USD">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030102558542"
      unitRef="USD">139037</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="4"
      id="Fxbrl_20261030102608414"
      unitRef="Percent">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261102105657492"
      unitRef="USD">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_20260901to20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20261030111828326"
      unitRef="Percent">0.25</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030105807911"
      unitRef="USD">860680</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030105847455"
      unitRef="USD">7411</us-gaap:PaymentsOfDebtIssuanceCosts>
    <mdcx:DebtInstrumentRedemptionLimitAmount
      contextRef="C_20260901_srtRangeAxis_srtMaximumMember_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030110050623"
      unitRef="USD">100000</mdcx:DebtInstrumentRedemptionLimitAmount>
    <mdcx:DebtDefaultBalanceIncreasePercentage
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20261030110100647"
      unitRef="Percent">0.20</mdcx:DebtDefaultBalanceIncreasePercentage>
    <mdcx:DebtInstrumentVolumeBasedRedemptionPercentageLimit
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20261030110112987"
      unitRef="Percent">0.05</mdcx:DebtInstrumentVolumeBasedRedemptionPercentageLimit>
    <mdcx:DebtInstrumentCovenantSharePriceThresholdPercentage
      contextRef="C_20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20261030110123286"
      unitRef="Percent">0.15</mdcx:DebtInstrumentCovenantSharePriceThresholdPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_20260901to20260901_srtRangeAxis_srtMaximumMember_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="2"
      id="Fxbrl_20261030110129046"
      unitRef="Percent">1.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault
      contextRef="C_20260901to20260901_usgaapDebtInstrumentAxis_mdcxNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      id="Fxbrl_20261030110147438">Upon the occurrence of trigger events, the lender may increase the outstanding balance by 5% for certain minor trigger events or 15% for certain major trigger events, subject to contractual limitations. Following an event of default, the lender may accelerate repayment, and default interest may accrue at a rate of up to 18% per annum, subject to applicable law.</us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030155354382">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debenture issued on September 17, 2025:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net balance as at December 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,245,543&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repayment of new debenture&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,180,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest accretion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,712&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest payment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;border-bottom:0.75pt solid #000000;width:12%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(96,393&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-bottom:0.75pt solid #000000;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;border-color:#000000;font-size:10pt;margin-bottom:0pt;margin-top:0pt"&gt;

                  &lt;tr style="background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:84%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Ending balance as of May 27, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:1%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:12%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;2,343,778&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;width:84%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Repayment of Yorkville debenture&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;margin-top:0pt;margin-bottom:0pt;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:right;margin-top:0pt;margin-bottom:0pt;width:12%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(2,343,778&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;margin-top:0pt;margin-bottom:0pt;width:2%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt"&gt;
                    &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:84%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Ending balance as of September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:1%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:12%"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);background-color:rgb(230, 239, 255);margin-top:0pt;margin-bottom:0pt;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtCurrent
      contextRef="C_20251231_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="Fxbrl_20260509022016774"
      unitRef="USD">5245543</us-gaap:DebtCurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20260101to20260527_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="F20260321061347346_19"
      unitRef="USD">3180084</us-gaap:RepaymentsOfDebt>
    <mdcx:ConvertibleDebtAccretionExpense
      contextRef="C_20260101to20260527_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="F20260321061347347_20"
      unitRef="USD">374712</mdcx:ConvertibleDebtAccretionExpense>
    <mdcx:RepaymentsOfInterest
      contextRef="C_20260101to20260527_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="F20260321061347347_21"
      unitRef="USD">96393</mdcx:RepaymentsOfInterest>
    <us-gaap:DebtCurrent
      contextRef="C_20260527_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="Fxbrl_20260810144141928"
      unitRef="USD">2343778</us-gaap:DebtCurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20260528to20260930_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="Fxbrl_20260810144324362"
      unitRef="USD">2343778</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtCurrent
      contextRef="C_20260930_usgaapLongtermDebtTypeAxis_mdcxDebentureContinuityOneMember"
      decimals="0"
      id="F20260321061347347_22"
      unitRef="USD">0</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20261030113548990">
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Note A and Note A-2&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Principal of Note A and Note A-2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;15,003,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Discount on debt&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(1,003,262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Debt issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(349,091&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Repayment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(860,680&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest accretion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;397,935&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Ending balance&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;13,188,164&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest Payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;403,726&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Note B issued on May 27, 2026:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:center;border-bottom:0.75pt solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Principal of Note B&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exchange to Note A-2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Debt issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;(265,909&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest accretion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;63,906&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;Ending balance&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;border-bottom:2.25pt double rgb(0, 0, 0);width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;7,797,997&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;border-bottom:2.25pt double rgb(0, 0, 0);width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(230, 239, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="padding-right:5.4pt;padding-left:16.2pt;vertical-align:bottom;text-align:justify;text-indent:-10.8pt;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Interest Payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:12%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;169,870&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810115824309"
      unitRef="USD">15003262</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810115904324"
      unitRef="USD">1003262</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810115933474"
      unitRef="USD">349091</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfDebt
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030112922884"
      unitRef="USD">860680</us-gaap:RepaymentsOfDebt>
    <mdcx:InterestAccretionDebt
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810115955476"
      unitRef="USD">397935</mdcx:InterestAccretionDebt>
    <us-gaap:NotesPayable
      contextRef="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810120017545"
      unitRef="USD">13188164</us-gaap:NotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteAAndNoteA2Member_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030112920421"
      unitRef="USD">403726</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810115850550"
      unitRef="USD">10000000</us-gaap:ProceedsFromNotesPayable>
    <mdcx:ExchangeRelatedToDebt
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030112941309"
      unitRef="USD">2000000</mdcx:ExchangeRelatedToDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810115924469"
      unitRef="USD">265909</us-gaap:PaymentsOfDebtIssuanceCosts>
    <mdcx:InterestAccretionDebt
      contextRef="C_20260101to20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810120007773"
      unitRef="USD">63906</mdcx:InterestAccretionDebt>
    <us-gaap:NotesPayable
      contextRef="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810120033798"
      unitRef="USD">7797997</us-gaap:NotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030112946988"
      unitRef="USD">169870</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="C_20260930_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20260810113217371"
      unitRef="USD">573596</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_20260930_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030111234462"
      unitRef="USD">289710</us-gaap:InterestPayableCurrent>
    <mdcx:InterestPayableNonCurrent
      contextRef="C_20260930_usgaapLongtermDebtTypeAxis_mdcxSecuredPromissoryNotesMember"
      decimals="0"
      id="Fxbrl_20261030111238097"
      unitRef="USD">283886</mdcx:InterestPayableNonCurrent>
    <us-gaap:RestrictedAssetsDisclosureTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260810014026005">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;13. Restricted Cash&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;As of September 30, 2026, cash of $8.08 million was held in a restricted deposit account maintained by a subsidiary of the Company pursuant to the Deposit Account Control Agreement entered into in connection with the Note B financing. The funds are subject to a first-ranking security interest in favour of the lender and are not available for general corporate purposes except in accordance with the financing arrangements. Accordingly, the balance has been presented as restricted cash in the condensed interim consolidated balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:RestrictedAssetsDisclosureTextBlock>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20260930_usgaapDebtInstrumentAxis_mdcxNoteBMember"
      decimals="-4"
      id="Fxbrl_20260810014041940"
      unitRef="USD">8080000.00</us-gaap:RestrictedCashCurrent>
    <mdcx:LiquidityTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260509031047316">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14. Liquidity and Going Concern&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. In addition to the ATM and Secured Promissory Notes (as defined herein), management believes that the Company has access to additional capital resources through public and/or private equity offerings, debt financings or other capital sources, including potential collaborations, licenses and other similar arrangements. However, it is possible that the Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into strategic alliances or other arrangements on favorable terms, or at all. Further, the terms of any financing may adversely affect the holdings or the rights of the Company&#x2019;s shareholders. If the Company is unable to secure additional capital, it may be required to take additional measures to reduce costs in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations. These measures could cause significant delays or entirely prevent the Company&#x2019;s continued efforts to progress its research and development program, pursue product portfolio expansion or commercialize its current or future products, each of which is critical to the realization of the Company&#x2019;s business plan and its future operations. The Company has reprioritized certain development programs and reduced the pace of planned expenditures while it evaluates potential strategic partnerships and other funding opportunities to support the continued advancement of these programs. This uncertainty, together with the Company&#x2019;s continued losses and outstanding debt obligations, indicates that substantial doubt exists about the Company&#x2019;s ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;&lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The Company is subject to risks associated with any specialty biotechnology company that has substantial expenditures for research and development. There can be no assurance that the Company's research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </mdcx:LiquidityTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260812123257109">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;15. Loss per share&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic and diluted net loss per share attributable to common shareholders was calculated as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Three Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net loss attributable to shareholders&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,181,335&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,935,753&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35,841,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(32,214,245&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Weighted average number of common shares outstanding &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,304,177&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;372,633&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,019,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;336,892&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basic and diluted net loss per share attributable to shareholders&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(95.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's potentially dilutive securities as of September 30, 2026 and 2025, include stock options and warrants. The Company excluded the potential common shares outstanding at each period end from the computation of diluted net loss per share attributable to common shareholders for the period ended September 30, 2026 and 2025 because including them would have had an anti-dilutive effect.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following potentially dilutive securities have been excluded from the computations of diluted weighted-average shares outstanding as they would be anti-dilutive:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%"&gt;

            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td colspan="2" style="width:67%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;white-space:nowrap"&gt;
                &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;For the Period Ended&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;white-space:nowrap"&gt;
                &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;white-space:nowrap"&gt;
                &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Stock options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140,200&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,150&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,636&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118,836&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;border-top:0.75pt solid #000000;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;border-top:0.75pt solid #000000;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;285,836&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;border-top:0.75pt solid #000000;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;155,986&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260812123321374">
        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Three Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Nine Months Ended September 30,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="padding-right:5.4pt;padding-left:5.4pt;vertical-align:bottom;white-space:nowrap;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net loss attributable to shareholders&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,181,335&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,935,753&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35,841,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(32,214,245&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Weighted average number of common shares outstanding &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,304,177&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;372,633&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,019,773&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;336,892&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basic and diluted net loss per share attributable to shareholders&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(35.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(95.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20260812123408401"
      unitRef="USD">-15181335</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20260812123424680"
      unitRef="USD">-20935753</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260812123436467"
      unitRef="USD">-35841183</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260812123614310"
      unitRef="USD">-32214245</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260701to20260930"
      decimals="0"
      id="Fxbrl_20260812123636698_xbrl_20260812123408401"
      unitRef="Share">1304177</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250701to20250930"
      decimals="0"
      id="Fxbrl_20260812123636698_xbrl_20260812123424680"
      unitRef="Share">372633</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260812123636698_xbrl_20260812123436467"
      unitRef="Share">1019773</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260812123636698_xbrl_20260812123614310"
      unitRef="Share">336892</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_20260812124007459"
      unitRef="USD_Per_Share">-11.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260701to20260930"
      decimals="2"
      id="Fxbrl_20260812123639038_xbrl_20260812123408401"
      unitRef="USD_Per_Share">-11.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250701to20250930"
      decimals="2"
      id="Fxbrl_20260812124022429"
      unitRef="USD_Per_Share">-56.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250701to20250930"
      decimals="2"
      id="Fxbrl_20260812123639038_xbrl_20260812123424680"
      unitRef="USD_Per_Share">-56.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20260812124050854"
      unitRef="USD_Per_Share">-35.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260101to20260930"
      decimals="2"
      id="Fxbrl_20260812123639038_xbrl_20260812123436467"
      unitRef="USD_Per_Share">-35.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250101to20250930"
      decimals="2"
      id="Fxbrl_20260812124058038"
      unitRef="USD_Per_Share">-95.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250101to20250930"
      decimals="2"
      id="Fxbrl_20260812123639038_xbrl_20260812123614310"
      unitRef="USD_Per_Share">-95.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260812123332775">
        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%"&gt;

            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td colspan="2" style="width:67%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;white-space:nowrap"&gt;
                &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;For the Period Ended&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;white-space:nowrap"&gt;
                &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2026&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;white-space:nowrap"&gt;
                &lt;p style="text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;September 30, 2025&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Stock options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140,200&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,150&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,636&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118,836&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;border-top:0.75pt solid #000000;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;border-top:0.75pt solid #000000;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;285,836&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:32%;padding-right:5.75pt;padding-left:5.75pt;vertical-align:top;border-top:0.75pt solid #000000;background-color:#e6efff"&gt;
                &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;155,986&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260101to20260930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mdcxStockOptionsMember"
      decimals="0"
      id="Fxbrl_20260812123410224"
      unitRef="Share">140200</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250101to20250930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mdcxStockOptionsMember"
      decimals="0"
      id="Fxbrl_20260812123540584"
      unitRef="Share">37150</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260101to20260930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapWarrantMember"
      decimals="0"
      id="Fxbrl_20260812123457576"
      unitRef="Share">145636</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250101to20250930_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapWarrantMember"
      decimals="0"
      id="Fxbrl_20260812123557337"
      unitRef="Share">118836</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260101to20260930"
      decimals="0"
      id="Fxbrl_20260812123505336"
      unitRef="Share">285836</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250101to20250930"
      decimals="0"
      id="Fxbrl_20260812123604792"
      unitRef="Share">155986</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_20260101to20260930"
      id="Fxbrl_20260810014241249">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;16.&lt;/strong&gt;&#160;&lt;strong&gt;Subsequent events&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Share Consolidation:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the Company's 2026 Annual General meeting and Special Meeting held on June 3, 2026, the Company's shareholders approved a proposal authorizing the Company's board of directors to effect a consolidation of the common shares at a ratio of up to 50 to 1. Subsequently, the Company's board of directors approved a share consolidation of the Company's common shares on a 50 to 1 basis, which became effective on October 12, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;All share and per share amounts in the accompanying unaudited condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the share consolidation for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;ATM Financing:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;&lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Subsequent to the period ended September 30, 2026, the Company completed sales under its ATM pursuant to which it issued 41,200 common shares for gross proceeds of approximately $240,013 or approximately $232,812 after incurring commissions payable to the Agents.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-top:10pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;&lt;span style="text-decoration:underline"&gt;Proposed SkinJect Business Combination:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:13px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;On November 4, 2026, the Company announced that SkinJect entered into a non-binding letter of intent with an undisclosed special purpose acquisition company for a proposed business combination involving SkinJect (the &#x201c;Business Combination&#x201d;) and concurrent equity financing. There can be no assurance that definitive agreements relating to the Business Combination will be signed, that the equity financing will be secured or that the transaction will be completed. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_20261012to20261012_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      id="Fxbrl_20261030131638250">50 to 1</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_20261012to20261012_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      id="Fxbrl_20261102103214064">50 to 1</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20261001to20261103_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember"
      decimals="0"
      id="Fxbrl_20260321152020250"
      unitRef="Share">41200</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20261001to20261103_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember"
      decimals="0"
      id="Fxbrl_20260321143243804"
      unitRef="USD">240013</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <mdcx:ProceedsFromCommonSharesNetOfCommissionsPayableToAgents
      contextRef="C_20261001to20261103_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_mdcxAtmAgreementMember"
      decimals="0"
      id="Fxbrl_20260321152044696"
      unitRef="USD">232812</mdcx:ProceedsFromCommonSharesNetOfCommissionsPayableToAgents>
</xbrl>
